BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY;  SARS study group. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319-1325. [PMID: 12711465 DOI: 10.1016/s0140-6736(03)13077-2] [Cited by in Crossref: 1852] [Cited by in F6Publishing: 1425] [Article Influence: 97.5] [Reference Citation Analysis]
Number Citing Articles
1 Lin HX, Feng Y, Tu X, Zhao X, Hsieh CH, Griffin L, Junop M, Zhang C. Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry. Virus Res 2011;160:283-93. [PMID: 21798295 DOI: 10.1016/j.virusres.2011.06.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
2 Yañez O, Osorio MI, Uriarte E, Areche C, Tiznado W, Pérez-Donoso JM, García-Beltrán O, González-Nilo F. In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease. Front Chem 2020;8:595097. [PMID: 33614592 DOI: 10.3389/fchem.2020.595097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Hung IF, Cheng VC, Wu AK, Tang BS, Chan KH, Chu CM, Wong MM, Hui WT, Poon LL, Tse DM, Chan KS, Woo PC, Lau SK, Peiris JS, Yuen KY. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004;10:1550-1557. [PMID: 15498155 DOI: 10.3201/eid1009.040058] [Cited by in Crossref: 174] [Cited by in F6Publishing: 153] [Article Influence: 9.7] [Reference Citation Analysis]
4 DeDiego ML, Nieto-Torres JL, Jiménez-Guardeño JM, Regla-Nava JA, Alvarez E, Oliveros JC, Zhao J, Fett C, Perlman S, Enjuanes L. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog 2011;7:e1002315. [PMID: 22028656 DOI: 10.1371/journal.ppat.1002315] [Cited by in Crossref: 122] [Cited by in F6Publishing: 113] [Article Influence: 11.1] [Reference Citation Analysis]
5 Woolhouse MEJ, Adair K. The diversity of human RNA viruses. Future Virol 2013;8:159-71. [PMID: 29503665 DOI: 10.2217/fvl.12.129] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
6 Lu HY, Huo N, Wang GF, Li HC, Nie LG, Que CL, Li J, Li YH, Gao XM, Zhao ZD, Zhuang H, Xu XY. Influence of factors on production of IgG antibody in SARS patients. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 723-725 [DOI: 10.11569/wcjd.v12.i3.723] [Reference Citation Analysis]
7 Dittmer U, Sutter K, Kassiotis G, Zelinskyy G, Bánki Z, Stoiber H, Santiago ML, Hasenkrug KJ. Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity. FEMS Microbiol Rev 2019;43:435-56. [PMID: 31087035 DOI: 10.1093/femsre/fuz012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
8 Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. J Clin Med 2021;10:779. [PMID: 33669185 DOI: 10.3390/jcm10040779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Egloff MP, Ferron F, Campanacci V, Longhi S, Rancurel C, Dutartre H, Snijder EJ, Gorbalenya AE, Cambillau C, Canard B. The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc Natl Acad Sci USA. 2004;101:3792-3796. [PMID: 15007178 DOI: 10.1073/pnas.0307877101] [Cited by in Crossref: 177] [Cited by in F6Publishing: 149] [Article Influence: 9.8] [Reference Citation Analysis]
10 Paasche A, Schiller M, Schirmeister T, Engels B. Mechanistic study of the reaction of thiol-containing enzymes with alpha,beta-unsaturated carbonyl substrates by computation and chemoassays. ChemMedChem 2010;5:869-80. [PMID: 20401893 DOI: 10.1002/cmdc.201000020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
11 Anderson LJ. Human bocavirus: a new viral pathogen. Clin Infect Dis 2007;44:911-2. [PMID: 17342640 DOI: 10.1086/512438] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
12 Wang B, Potter SJ, Lin Y, Cunningham AL, Dwyer DE, Su Y, Ma X, Hou Y, Saksena NK. Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification. J Clin Microbiol 2005;43:2339-44. [PMID: 15872263 DOI: 10.1128/JCM.43.5.2339-2344.2005] [Cited by in Crossref: 102] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
13 Shum KT, Tanner JA. Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase. Chembiochem 2008;9:3037-45. [PMID: 19031435 DOI: 10.1002/cbic.200800491] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
14 Millet JK, Kien F, Cheung CY, Siu YL, Chan WL, Li H, Leung HL, Jaume M, Bruzzone R, Peiris JS, Altmeyer RM, Nal B. Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage. PLoS One 2012;7:e49566. [PMID: 23185364 DOI: 10.1371/journal.pone.0049566] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
15 Abdel Moniem A, Radwan MA, Yousef AI. COVID-19 and cardiovascular disease: Manifestations, pathophysiology, vaccination, and long-term implication. Current Medical Research and Opinion. [DOI: 10.1080/03007995.2022.2078081] [Reference Citation Analysis]
16 Seifi T, Reza Kamali A. Antiviral performance of graphene-based materials with emphasis on COVID-19: A review. Med Drug Discov 2021;:100099. [PMID: 34056572 DOI: 10.1016/j.medidd.2021.100099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhu H, Wang Q, Zhang T, Liu X, Dai R, Wu P, Bai G, Wang Y, Zhou P, Luo L. Initial Public-Health Emergency Response to SARS and COVID-19 Pandemics in Mainland China: A Retrospective Comparative Study. Risk Manag Healthc Policy 2021;14:4199-209. [PMID: 34675714 DOI: 10.2147/RMHP.S324431] [Reference Citation Analysis]
18 Sun Y, Zhang H, Shi J, Zhang Z, Gong R. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus. Viruses 2017;9:E255. [PMID: 28906430 DOI: 10.3390/v9090255] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
19 Xue X, Yu H, Yang H, Xue F, Wu Z, Shen W, Li J, Zhou Z, Ding Y, Zhao Q, Zhang XC, Liao M, Bartlam M, Rao Z. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J Virol 2008;82:2515-27. [PMID: 18094151 DOI: 10.1128/JVI.02114-07] [Cited by in Crossref: 244] [Cited by in F6Publishing: 148] [Article Influence: 16.3] [Reference Citation Analysis]
20 Lu S; Editors of Emerging Microbes & Infections. Future Science Prize Goes to EMI Editorial Members and the Science of Emerging Infections. Emerg Microbes Infect 2021;:1-5. [PMID: 34919019 DOI: 10.1080/22221751.2021.2020599] [Reference Citation Analysis]
21 Hsu HH, Tzao C, Wu CP, Chang WC, Tsai CL, Tung HJ, Chen CY. Correlation of high-resolution CT, symptoms, and pulmonary function in patients during recovery from severe acute respiratory syndrome. Chest 2004;126:149-58. [PMID: 15249456 DOI: 10.1378/chest.126.1.149] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
22 Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020;94. [PMID: 31996437 DOI: 10.1128/jvi.00127-20] [Cited by in Crossref: 1924] [Cited by in F6Publishing: 1373] [Article Influence: 962.0] [Reference Citation Analysis]
23 Makoti P, Fielding BC. HIV and Human Coronavirus Coinfections: A Historical Perspective. Viruses. 2020;12. [PMID: 32858801 DOI: 10.3390/v12090937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome Diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003;361:1730-3. [PMID: 12767752 DOI: 10.1016/s0140-6736(03)13376-4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
25 Nickbakhsh S, Ho A, Marques DFP, McMenamin J, Gunson RN, Murcia PR. Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019. J Infect Dis 2020;222:17-25. [PMID: 32296837 DOI: 10.1093/infdis/jiaa185] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 36.5] [Reference Citation Analysis]
26 Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. [PMID: 16968120 DOI: 10.1371/journal.pmed.0030343] [Cited by in Crossref: 694] [Cited by in F6Publishing: 615] [Article Influence: 46.3] [Reference Citation Analysis]
27 Clem AL, Sims J, Telang S, Eaton JW, Chesney J. Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primers. Virol J 2007;4:65. [PMID: 17598900 DOI: 10.1186/1743-422X-4-65] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
28 Brug J, Aro AR, Richardus JH. Risk perceptions and behaviour: towards pandemic control of emerging infectious diseases : international research on risk perception in the control of emerging infectious diseases. Int J Behav Med 2009;16:3-6. [PMID: 19127440 DOI: 10.1007/s12529-008-9000-x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
29 Muttineni R, Kammili N, Bingi TC, Rao M R, Putty K, Dholaniya PS, Puli RK, Pakalapati S, S S, K S, Doodipala MR, Upadhyay AA, Bosinger SE, Amara RR, Kondapi AK. Clinical and whole genome characterization of SARS-CoV-2 in India. PLoS One 2021;16:e0246173. [PMID: 33529260 DOI: 10.1371/journal.pone.0246173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
30 Wang FS, Chu FL, Jin L, Li YG, Zhang Z, Xu D, Shi M, Wu H, Moulds JM. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome. Clin Exp Immunol 2005;139:112-9. [PMID: 15606620 DOI: 10.1111/j.1365-2249.2005.02681.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
31 Krähling V, Stein DA, Spiegel M, Weber F, Mühlberger E. Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity. J Virol 2009;83:2298-309. [PMID: 19109397 DOI: 10.1128/JVI.01245-08] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 5.2] [Reference Citation Analysis]
32 Follis KE, York J, Nunberg JH. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Virology 2006;350:358-69. [PMID: 16519916 DOI: 10.1016/j.virol.2006.02.003] [Cited by in Crossref: 142] [Cited by in F6Publishing: 121] [Article Influence: 8.9] [Reference Citation Analysis]
33 Braden CR, Dowell SF, Jernigan DB, Hughes JM. Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome. Emerg Infect Dis 2013;19:864-9. [PMID: 23731871 DOI: 10.3201/eid1906.130192] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
34 Yuen CK, Lam JY, Wong WM, Mak LF, Wang X, Chu H, Cai JP, Jin DY, To KK, Chan JF, Yuen KY, Kok KH. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect. 2020;9:1418-1428. [PMID: 32529952 DOI: 10.1080/22221751.2020.1780953] [Cited by in Crossref: 160] [Cited by in F6Publishing: 143] [Article Influence: 80.0] [Reference Citation Analysis]
35 Chu CM, Poon LL, Cheng VC, Chan KS, Hung IF, Wong MM, Chan KH, Leung WS, Tang BS, Chan VL, Ng WL, Sim TC, Ng PW, Law KI, Tse DM, Peiris JS, Yuen KY. Initial viral load and the outcomes of SARS. CMAJ. 2004;171:1349-1352. [PMID: 15557587 DOI: 10.1503/cmaj.1040398] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 6.6] [Reference Citation Analysis]
36 Zhang D, Zhu L, Wang Y, Li P, Gao Y. Translational Control of COVID-19 and Its Therapeutic Implication. Front Immunol 2022;13:857490. [PMID: 35422818 DOI: 10.3389/fimmu.2022.857490] [Reference Citation Analysis]
37 Perret C, Le Corre N, Castro-Rodriguez JA. Emergent Pneumonia in Children. Front Pediatr 2021;9:676296. [PMID: 34222146 DOI: 10.3389/fped.2021.676296] [Reference Citation Analysis]
38 Woo PC, Huang Y, Lau SK, Tsoi HW, Yuen KY. In silico analysis of ORF1ab in coronavirus HKU1 genome reveals a unique putative cleavage site of coronavirus HKU1 3C-like protease. Microbiol Immunol 2005;49:899-908. [PMID: 16237267 DOI: 10.1111/j.1348-0421.2005.tb03681.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
39 Bairwa M, Kumar R, Ajmal M, Bahurupi Y, Kant R. Predictors of critical illness and mortality based on symptoms and initial physical examination for patients with SARS-CoV-2: A retrospective cohort study. J Infect Public Health 2021;14:1028-34. [PMID: 34153728 DOI: 10.1016/j.jiph.2021.06.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Shi CS, Qi HY, Boularan C, Huang NN, Abu-Asab M, Shelhamer JH, Kehrl JH. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J Immunol 2014;193:3080-9. [PMID: 25135833 DOI: 10.4049/jimmunol.1303196] [Cited by in Crossref: 236] [Cited by in F6Publishing: 224] [Article Influence: 29.5] [Reference Citation Analysis]
41 Zhao J, Zhao J, Van Rooijen N, Perlman S. Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice. PLoS Pathog 2009;5:e1000636. [PMID: 19851468 DOI: 10.1371/journal.ppat.1000636] [Cited by in Crossref: 106] [Cited by in F6Publishing: 109] [Article Influence: 8.2] [Reference Citation Analysis]
42 Agrawal AS, Garron T, Tao X, Peng BH, Wakamiya M, Chan TS, Couch RB, Tseng CT. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol 2015;89:3659-70. [PMID: 25589660 DOI: 10.1128/JVI.03427-14] [Cited by in Crossref: 151] [Cited by in F6Publishing: 120] [Article Influence: 21.6] [Reference Citation Analysis]
43 Chen S, Jonas F, Shen C, Hilgenfeld R. Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode. Protein Cell 2010;1:59-74. [PMID: 21203998 DOI: 10.1007/s13238-010-0011-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
44 Amber R, Adnan M, Tariq A, Mussarat S. A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms. J Pharm Pharmacol 2017;69:109-22. [PMID: 27905101 DOI: 10.1111/jphp.12669] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
45 Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8 Suppl:S9-14. [PMID: 15018127 DOI: 10.1046/j.1440-1843.2003.00518.x] [Cited by in Crossref: 320] [Cited by in F6Publishing: 261] [Article Influence: 17.8] [Reference Citation Analysis]
46 Nicholls JM, Butany J, Poon LL, Chan KH, Beh SL, Poutanen S, Peiris JS, Wong M. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med 2006;3:e27. [PMID: 16379499 DOI: 10.1371/journal.pmed.0030027] [Cited by in Crossref: 102] [Cited by in F6Publishing: 99] [Article Influence: 6.4] [Reference Citation Analysis]
47 Stradner MH, Dejaco C, Zwerina J, Fritsch-Stork RD. Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic. Front Med (Lausanne) 2020;7:562142. [PMID: 33154972 DOI: 10.3389/fmed.2020.562142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
48 Salto-Tellez M, Tan E, Lim B. ARDS in SARS: cytokine mediators and treatment implications. Cytokine 2005;29:92-4. [PMID: 15598444 DOI: 10.1016/j.cyto.2004.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
49 Ghosh AK, Xi K, Johnson ME, Baker SC, Mesecar AD. Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy. Annu Rep Med Chem 2007;41:183-96. [PMID: 19649165 DOI: 10.1016/S0065-7743(06)41011-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
50 Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L, Mo L, Ye S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao Z. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A 2003;100:13190-5. [PMID: 14585926 DOI: 10.1073/pnas.1835675100] [Cited by in Crossref: 566] [Cited by in F6Publishing: 531] [Article Influence: 29.8] [Reference Citation Analysis]
51 Kaye M. SARS-associated coronavirus replication in cell lines. Emerg Infect Dis 2006;12:128-33. [PMID: 16494729 DOI: 10.3201/eid1201.050496] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 4.4] [Reference Citation Analysis]
52 Kucukoglu K, Faydalı N, Bul D. What are the drugs having potential against COVID-19? Med Chem Res 2020;:1-21. [PMID: 32929317 DOI: 10.1007/s00044-020-02625-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Thanigaimalai P, Konno S, Yamamoto T, Koiwai Y, Taguchi A, Takayama K, Yakushiji F, Akaji K, Kiso Y, Kawasaki Y, Chen SE, Naser-Tavakolian A, Schön A, Freire E, Hayashi Y. Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship study. Eur J Med Chem 2013;65:436-47. [PMID: 23747811 DOI: 10.1016/j.ejmech.2013.05.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
54 Zhu J, Xiao G, Xu Y, Yuan F, Zheng C, Liu Y, Yan H, Cole DK, Bell JI, Rao Z, Tien P, Gao GF. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors. Biochem Biophys Res Commun 2004;319:283-8. [PMID: 15158473 DOI: 10.1016/j.bbrc.2004.04.141] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 3.9] [Reference Citation Analysis]
55 Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol. 2005;18:1-10. [PMID: 15272286 DOI: 10.1038/modpathol.3800247] [Cited by in Crossref: 209] [Cited by in F6Publishing: 186] [Article Influence: 12.3] [Reference Citation Analysis]
56 Hu D, Shao C, Guan W, Su Z, Sun J. Studies on the interactions of Ti-containing polyoxometalates (POMs) with SARS-CoV 3CLpro by molecular modeling. J Inorg Biochem 2007;101:89-94. [PMID: 17049610 DOI: 10.1016/j.jinorgbio.2006.08.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
57 Ogando NS, Dalebout TJ, Zevenhoven-Dobbe JC, Limpens RWAL, van der Meer Y, Caly L, Druce J, de Vries JJC, Kikkert M, Bárcena M, Sidorov I, Snijder EJ. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J Gen Virol 2020;101:925-40. [PMID: 32568027 DOI: 10.1099/jgv.0.001453] [Cited by in Crossref: 170] [Cited by in F6Publishing: 151] [Article Influence: 85.0] [Reference Citation Analysis]
58 Chng WJ, Lai HC, Earnest A, Kuperan P. Haematological parameters in severe acute respiratory syndrome. Clin Lab Haematol 2005;27:15-20. [PMID: 15686503 DOI: 10.1111/j.1365-2257.2004.00652.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
59 Geller C, Varbanov M, Duval RE. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses 2012;4:3044-68. [PMID: 23202515 DOI: 10.3390/v4113044] [Cited by in Crossref: 204] [Cited by in F6Publishing: 165] [Article Influence: 20.4] [Reference Citation Analysis]
60 Conly JM, Johnston BL. SARS : A Tale of Two Epidemics. Can J Infect Dis 2003;14:147-9. [PMID: 18159447 DOI: 10.1155/2003/912170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
61 Feng C, Liu Y, Lyu G, Shang S, Xia H, Zhang J, Irwin DM, Wang Z, Zhang S, Harrison P. Adaptive Evolution of the Fox Coronavirus Based on Genome-Wide Sequence Analysis. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/9627961] [Reference Citation Analysis]
62 Poon LL, Chan KH, Peiris JS. Crouching tiger, hidden dragon: the laboratory diagnosis of severe acute respiratory syndrome. Clin Infect Dis 2004;38:297-9. [PMID: 14699466 DOI: 10.1086/380848] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
63 Kong WP, Xu L, Stadler K, Ulmer JB, Abrignani S, Rappuoli R, Nabel GJ. Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization. J Virol 2005;79:13915-23. [PMID: 16254327 DOI: 10.1128/JVI.79.22.13915-13923.2005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
64 Nie Y, Wang G, Shi X, Zhang H, Qiu Y, He Z, Wang W, Lian G, Yin X, Du L, Ren L, Wang J, He X, Li T, Deng H, Ding M. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis 2004;190:1119-26. [PMID: 15319862 DOI: 10.1086/423286] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 5.3] [Reference Citation Analysis]
65 Ryu YB, Jeong HJ, Kim JH, Kim YM, Park JY, Kim D, Nguyen TT, Park SJ, Chang JS, Park KH, Rho MC, Lee WS. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. Bioorg Med Chem 2010;18:7940-7. [PMID: 20934345 DOI: 10.1016/j.bmc.2010.09.035] [Cited by in Crossref: 210] [Cited by in F6Publishing: 184] [Article Influence: 17.5] [Reference Citation Analysis]
66 Lau SKP, Wong ACP, Luk HKH, Li KSM, Fung J, He Z, Cheng FKK, Chan TTY, Chu S, Aw-Yong KL, Lau TCK, Fung KSC, Woo PCY. Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells. Emerg Infect Dis 2020;26:2961-5. [PMID: 32730733 DOI: 10.3201/eid2612.202308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
67 Gorgulla C, Padmanabha Das KM, Leigh KE, Cespugli M, Fischer PD, Wang ZF, Tesseyre G, Pandita S, Shnapir A, Calderaio A, Gechev M, Rose A, Lewis N, Hutcheson C, Yaffe E, Luxenburg R, Herce HD, Durmaz V, Halazonetis TD, Fackeldey K, Patten JJ, Chuprina A, Dziuba I, Plekhova A, Moroz Y, Radchenko D, Tarkhanova O, Yavnyuk I, Gruber C, Yust R, Payne D, Näär AM, Namchuk MN, Davey RA, Wagner G, Kinney J, Arthanari H. A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening. iScience 2021;24:102021. [PMID: 33426509 DOI: 10.1016/j.isci.2020.102021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
68 He ML, Zheng BJ, Chen Y, Wong KL, Huang JD, Lin MC, Peng Y, Yuen KY, Sung JJ, Kung HF. Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus. FEBS Lett 2006;580:2414-20. [PMID: 16638566 DOI: 10.1016/j.febslet.2006.03.066] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
69 Drosten C, Chiu LL, Panning M, Leong HN, Preiser W, Tam JS, Günther S, Kramme S, Emmerich P, Ng WL, Schmitz H, Koay ES. Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol 2004;42:2043-7. [PMID: 15131168 DOI: 10.1128/JCM.42.5.2043-2047.2004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
70 Canal B, Fujisawa R, McClure AW, Deegan TD, Wu M, Ulferts R, Weissmann F, Drury LS, Bertolin AP, Zeng J, Beale R, Howell M, Labib K, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease. Biochem J 2021;478:2465-79. [PMID: 34198324 DOI: 10.1042/BCJ20210199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
71 Gui M, Song W, Zhou H, Xu J, Chen S, Xiang Y, Wang X. Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res 2017;27:119-29. [PMID: 28008928 DOI: 10.1038/cr.2016.152] [Cited by in Crossref: 361] [Cited by in F6Publishing: 297] [Article Influence: 60.2] [Reference Citation Analysis]
72 Renu K, Prasanna PL, Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci 2020;255:117839. [PMID: 32450165 DOI: 10.1016/j.lfs.2020.117839] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 37.5] [Reference Citation Analysis]
73 Wu K, Peng G, Wilken M, Geraghty RJ, Li F. Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus. J Biol Chem. 2012;287:8904-8911. [PMID: 22291007 DOI: 10.1074/jbc.m111.325803] [Cited by in Crossref: 150] [Cited by in F6Publishing: 105] [Article Influence: 15.0] [Reference Citation Analysis]
74 Khodaei F, Ahsan A, Chamanifard M, Zamiri MJ, Ommati MM. Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor. J Biochem Mol Toxicol 2020;34:e22594. [PMID: 32770858 DOI: 10.1002/jbt.22594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
75 Lau SK, Yip CC, Lung DC, Lee P, Que TL, Lau YL, Chan KH, Woo PC, Yuen KY. Detection of human rhinovirus C in fecal samples of children with gastroenteritis. J Clin Virol 2012;53:290-6. [PMID: 22317907 DOI: 10.1016/j.jcv.2012.01.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
76 Zhang Z, Ma P, Ahmed R, Wang J, Akin D, Soto F, Liu BF, Li P, Demirci U. Advanced Point-of-Care Testing Technologies for Human Acute Respiratory Virus Detection. Adv Mater 2022;34:e2103646. [PMID: 34623709 DOI: 10.1002/adma.202103646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
77 Han MG, Cheon DS, Zhang X, Saif LJ. Cross-protection against a human enteric coronavirus and a virulent bovine enteric coronavirus in gnotobiotic calves. J Virol 2006;80:12350-6. [PMID: 16971444 DOI: 10.1128/JVI.00402-06] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
78 Lee YS, Chen CH, Chao A, Chen ES, Wei ML, Chen LK, Yang KD, Lin MC, Wang YH, Liu JW, Eng HL, Chiang PC, Wu TS, Tsao KC, Huang CG, Tien YJ, Wang TH, Wang HS, Lee YS. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). BMC Genomics 2005;6:132. [PMID: 16174304 DOI: 10.1186/1471-2164-6-132] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
79 Smales FC, Samaranyake LP. Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 1: a deadly viral epidemic begins. Br Dent J 2003;195:557-61. [PMID: 14631425 DOI: 10.1038/sj.bdj.4810723] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
80 Barin F. [Viral safety of biologicals]. Ann Pharm Fr 2008;66:129-39. [PMID: 18706341 DOI: 10.1016/j.pharma.2008.05.004] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
81 Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis. 2004;4:337-348. [PMID: 15172342 DOI: 10.1016/s1473-3099(04)01044-8] [Cited by in Crossref: 418] [Cited by in F6Publishing: 164] [Article Influence: 23.2] [Reference Citation Analysis]
82 Zhou J, Chu H, Li C, Wong BH, Cheng ZS, Poon VK, Sun T, Lau CC, Wong KK, Chan JY, Chan JF, To KK, Chan KH, Zheng BJ, Yuen KY. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis. 2014;209:1331-1342. [PMID: 24065148 DOI: 10.1093/infdis/jit504] [Cited by in Crossref: 258] [Cited by in F6Publishing: 252] [Article Influence: 28.7] [Reference Citation Analysis]
83 Poudel U, Subedi D, Pantha S, Dhakal S. Animal coronaviruses and coronavirus disease 2019: Lesson for One Health approach. Open Vet J 2020;10:239-51. [PMID: 33282694 DOI: 10.4314/ovj.v10i3.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
84 Roper RL, Rehm KE. SARS vaccines: where are we? Expert Rev Vaccines 2009;8:887-98. [PMID: 19538115 DOI: 10.1586/erv.09.43] [Cited by in Crossref: 110] [Cited by in F6Publishing: 106] [Article Influence: 8.5] [Reference Citation Analysis]
85 Janice Oh HL, Ken-En Gan S, Bertoletti A, Tan YJ. Understanding the T cell immune response in SARS coronavirus infection. Emerg Microbes Infect 2012;1:e23. [PMID: 26038429 DOI: 10.1038/emi.2012.26] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
86 Lu L, Manopo I, Leung BP, Chng HH, Ling AE, Chee LL, Ooi EE, Chan SW, Kwang J. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:1570-6. [PMID: 15071006 DOI: 10.1128/JCM.42.4.1570-1576.2004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
87 Martina BE, Haagmans BL, Kuiken T, Fouchier RA, Rimmelzwaan GF, Van Amerongen G, Peiris JS, Lim W, Osterhaus AD. Virology: SARS virus infection of cats and ferrets. Nature 2003;425:915. [PMID: 14586458 DOI: 10.1038/425915a] [Cited by in Crossref: 390] [Cited by in F6Publishing: 355] [Article Influence: 20.5] [Reference Citation Analysis]
88 Yan B, Chu H, Yang D, Sze KH, Lai PM, Yuan S, Shuai H, Wang Y, Kao RY, Chan JF, Yuen KY. Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication. Viruses. 2019;11:73. [PMID: 30654597 DOI: 10.3390/v11010073] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 35.3] [Reference Citation Analysis]
89 Calvo E, DeDiego ML, García P, López JA, Pérez-Breña P, Falcón A. Severe acute respiratory syndrome coronavirus accessory proteins 6 and 9b interact in vivo. Virus Res 2012;169:282-8. [PMID: 22820404 DOI: 10.1016/j.virusres.2012.07.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
90 Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 2003;100:12995-3000. [PMID: 14569023 DOI: 10.1073/pnas.1735582100] [Cited by in Crossref: 264] [Cited by in F6Publishing: 255] [Article Influence: 13.9] [Reference Citation Analysis]
91 Ng MH, Lau KM, Li L, Cheng SH, Chan WY, Hui PK, Zee B, Leung CB, Sung JJ. Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis 2004;190:515-8. [PMID: 15243926 DOI: 10.1086/421523] [Cited by in Crossref: 101] [Cited by in F6Publishing: 94] [Article Influence: 5.6] [Reference Citation Analysis]
92 Gutierrez-Villagomez JM, Campos-García T, Molina-Torres J, López MG, Vázquez-Martínez J. Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). J Phys Chem Lett 2020;11:8008-16. [PMID: 32840378 DOI: 10.1021/acs.jpclett.0c01685] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
93 Li J, Shen W, Liao M, Bartlam M. Preliminary crystallographic analysis of avian infectious bronchitis virus main protease. Acta Crystallogr Sect F Struct Biol Cryst Commun 2007;63:24-6. [PMID: 17183167 DOI: 10.1107/S1744309106052341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
94 Shi Y, Yang DH, Xiong J, Jia J, Huang B, Jin YX. Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. Cell Res. 2005;15:193-200. [PMID: 15780182 DOI: 10.1038/sj.cr.7290286] [Cited by in Crossref: 182] [Cited by in F6Publishing: 122] [Article Influence: 10.7] [Reference Citation Analysis]
95 Owolabi T, Kwolek S. Managing obstetrical patients during severe acute respiratory syndrome outbreak. J Obstet Gynaecol Can 2004;26:35-41. [PMID: 14715124 DOI: 10.1016/s1701-2163(16)30694-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
96 Majumdar S, Murphy PM. Chemokine Regulation During Epidemic Coronavirus Infection. Front Pharmacol 2020;11:600369. [PMID: 33613280 DOI: 10.3389/fphar.2020.600369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
97 Wertheim JO, Chu DK, Peiris JS, Kosakovsky Pond SL, Poon LL. A case for the ancient origin of coronaviruses. J Virol 2013;87:7039-45. [PMID: 23596293 DOI: 10.1128/JVI.03273-12] [Cited by in Crossref: 110] [Cited by in F6Publishing: 61] [Article Influence: 12.2] [Reference Citation Analysis]
98 Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A 2004;101:6641-6. [PMID: 15096611 DOI: 10.1073/pnas.0401939101] [Cited by in Crossref: 294] [Cited by in F6Publishing: 285] [Article Influence: 16.3] [Reference Citation Analysis]
99 Zhao J, Wang W, Wang W, Zhao Z, Zhang Y, Lv P, Ren F, Gao XM. Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS. Clin Vaccine Immunol 2007;14:839-46. [PMID: 17475765 DOI: 10.1128/CVI.00432-06] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
100 Cheng A, Zhang W, Xie Y, Jiang W, Arnold E, Sarafianos SG, Ding J. Expression, purification, and characterization of SARS coronavirus RNA polymerase. Virology 2005;335:165-76. [PMID: 15840516 DOI: 10.1016/j.virol.2005.02.017] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 4.6] [Reference Citation Analysis]
101 Severance EG, Bossis I, Dickerson FB, Stallings CR, Origoni AE, Sullens A, Yolken RH, Viscidi RP. Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population. Clin Vaccine Immunol 2008;15:1805-10. [PMID: 18945884 DOI: 10.1128/CVI.00124-08] [Cited by in Crossref: 77] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
102 Jansson AM. Structure of alphacoronavirus transmissible gastroenteritis virus nsp1 has implications for coronavirus nsp1 function and evolution. J Virol 2013;87:2949-55. [PMID: 23269811 DOI: 10.1128/JVI.03163-12] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
103 Nagata N, Iwata N, Hasegawa H, Asahi-Ozaki Y, Sato Y, Harashima A, Morikawa S, Saijo M, Itamura S, Saito T, Odagiri T, Tashiro M, Ami Y, Sata T. Pathological and virological analyses of severe acute respiratory syndrome-associated coronavirus infections in experimental animals. Adv Exp Med Biol 2006;581:515-8. [PMID: 17037588 DOI: 10.1007/978-0-387-33012-9_92] [Reference Citation Analysis]
104 Wong SY, Lim WW, Que TL, Au DM. Reflection on SARS precautions in a severe intellectual disabilities hospital in Hong Kong. J Intellect Disabil Res 2005;49:379-84. [PMID: 15817055 DOI: 10.1111/j.1365-2788.2005.00687.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
105 Chang Z, Hu Z. RNAi therapeutics: can siRNAs conquer SARS? Gene Ther 2006;13:871-2. [PMID: 17262907 DOI: 10.1038/sj.gt.3302682] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
106 Zhang C, Liu X, Wang Y, Lu J, Zheng H, Xiong S, Zhang M, Liu Q. Immune responses and histopathological changes in rabbits immunized with inactivated SARS coronavirus. Virol Sin 2007;22:360-5. [DOI: 10.1007/s12250-007-0033-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
107 Lutchmansingh DD, Knauert MP, Antin-Ozerkis DE, Chupp G, Cohn L, Dela Cruz CS, Ferrante LE, Herzog EL, Koff J, Rochester CL, Ryu C, Singh I, Tickoo M, Winks V, Gulati M, Possick JD. A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY: Learning From the Past, Looking to the Future. Chest 2021;159:949-58. [PMID: 33159907 DOI: 10.1016/j.chest.2020.10.067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
108 Li S, Lin L, Wang H, Yin J, Ren Y, Zhao Z, Wen J, Zhou C, Zhang X, Li X, Wang J, Zhou Z, Liu J, Shao J, Lei T, Fang J, Xu N, Liu S. The epitope study on the SARS-CoV nucleocapsid protein. Genomics Proteomics Bioinformatics 2003;1:198-206. [PMID: 15629032 DOI: 10.1016/s1672-0229(03)01025-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
109 Yuan X, Li J, Shan Y, Yang Z, Zhao Z, Chen B, Yao Z, Dong B, Wang S, Chen J, Cong Y. Subcellular localization and membrane association of SARS-CoV 3a protein. Virus Res 2005;109:191-202. [PMID: 15763150 DOI: 10.1016/j.virusres.2005.01.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
110 Hartley PD, Tillett RL, AuCoin DP, Sevinsky JR, Xu Y, Gorzalski A, Pandori M, Buttery E, Hansen H, Picker MA, Rossetto CC, Verma SC. Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene. J Genet Genomics 2021;48:40-51. [PMID: 33820739 DOI: 10.1016/j.jgg.2021.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
111 Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens. Global Health 2017;13:9. [PMID: 28179007 DOI: 10.1186/s12992-017-0233-9] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 17.6] [Reference Citation Analysis]
112 Zhong X, Yang H, Guo ZF, Sin WY, Chen W, Xu J, Fu L, Wu J, Mak CK, Cheng CS, Yang Y, Cao S, Wong TY, Lai ST, Xie Y, Guo Z. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. J Virol 2005;79:3401-8. [PMID: 15731234 DOI: 10.1128/JVI.79.6.3401-3408.2005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
113 Ahmed S, Khan S, Imran I, Al Mughairbi F, Sheikh FS, Hussain J, Khan A, Al-Harrasi A. Vaccine Development against COVID-19: Study from Pre-Clinical Phases to Clinical Trials and Global Use. Vaccines (Basel) 2021;9:836. [PMID: 34451961 DOI: 10.3390/vaccines9080836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Tomlinson B, Cockram C. SARS: experience at Prince of Wales Hospital, Hong Kong. Lancet. 2003;361:1486-1487. [PMID: 12737853 DOI: 10.1016/s0140-6736(03)13218-7] [Cited by in Crossref: 100] [Cited by in F6Publishing: 66] [Article Influence: 5.3] [Reference Citation Analysis]
115 Sharshov K, Solomatina M, Kurskaya O, Kovalenko I, Kholina E, Fedorov V, Meerovich G, Rubin A, Strakhovskaya M. The Photosensitizer Octakis(cholinyl)zinc Phthalocyanine with Ability to Bind to a Model Spike Protein Leads to a Loss of SARS-CoV-2 Infectivity In Vitro When Exposed to Far-Red LED. Viruses 2021;13:643. [PMID: 33918615 DOI: 10.3390/v13040643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Ahmed-Hassan H, Sisson B, Shukla RK, Wijewantha Y, Funderburg NT, Li Z, Hayes D Jr, Demberg T, Liyanage NPM. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections. Front Immunol 2020;11:1979. [PMID: 32973803 DOI: 10.3389/fimmu.2020.01979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
117 Gutiérrez-Álvarez J, Honrubia JM, Fernández-Delgado R, Wang L, Castaño-Rodríguez C, Zúñiga S, Sola I, Enjuanes L. Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection. mBio 2021;12:e00103-21. [PMID: 33653888 DOI: 10.1128/mBio.00103-21] [Reference Citation Analysis]
118 Mortaz E, Tabarsi P, Varahram M, Folkerts G, Adcock IM. The Immune Response and Immunopathology of COVID-19. Front Immunol 2020;11:2037. [PMID: 32983152 DOI: 10.3389/fimmu.2020.02037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
119 Okada M, Okuno Y, Hashimoto S, Kita Y, Kanamaru N, Nishida Y, Tsunai Y, Inoue R, Nakatani H, Fukamizu R, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Kase T, Takemoto Y, Yoshida S, Peiris JS, Chen PJ, Yamamoto N, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M. Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models. Vaccine 2007;25:3038-40. [PMID: 17289225 DOI: 10.1016/j.vaccine.2007.01.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
120 Tan TT, Tan BH, Kurup A, Oon LL, Heng D, Thoe SY, Bai XL, Chan KP, Ling AE. Atypical SARS and Escherichia coli bacteremia. Emerg Infect Dis 2004;10:349-52. [PMID: 15030711 DOI: 10.3201/eid1002.030501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
121 Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S. Rationale for targeting complement in COVID-19. EMBO Mol Med 2020;12:e12642. [PMID: 32559343 DOI: 10.15252/emmm.202012642] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 21.0] [Reference Citation Analysis]
122 Fong CH, Cai JP, Dissanayake TK, Chen LL, Choi CY, Wong LH, Ng AC, Pang PKP, Ho DT, Poon RW, Chung TW, Sridhar S, Chan KH, Chan JF, Hung IF, Yuen KY, To KK. Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay. Int J Mol Sci 2020;21:E6595. [PMID: 32916926 DOI: 10.3390/ijms21186595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
123 Zhu X, Liu Q, Du L, Lu L, Jiang S. Receptor-binding domain as a target for developing SARS vaccines. J Thorac Dis 2013;5 Suppl 2:S142-8. [PMID: 23977435 DOI: 10.3978/j.issn.2072-1439.2013.06.06] [Cited by in F6Publishing: 37] [Reference Citation Analysis]
124 Li G, Zhao Z, Chen L, Zhou Y. Mild severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1182-3. [PMID: 14531381 DOI: 10.3201/eid0909.030461] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
125 Reghunathan R, Jayapal M, Hsu LY, Chng HH, Tai D, Leung BP, Melendez AJ. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol 2005;6:2. [PMID: 15655079 DOI: 10.1186/1471-2172-6-2] [Cited by in Crossref: 200] [Cited by in F6Publishing: 1] [Article Influence: 11.8] [Reference Citation Analysis]
126 Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJ, van der Meulen J, Koerten HK, Mommaas AM. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol. 2006;80:5927-5940. [PMID: 16731931 DOI: 10.1128/jvi.02501-05] [Cited by in Crossref: 316] [Cited by in F6Publishing: 246] [Article Influence: 19.8] [Reference Citation Analysis]
127 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-544. [PMID: 32123347 DOI: 10.1038/s41564-020-0695-z] [Cited by in Crossref: 2735] [Cited by in F6Publishing: 2291] [Article Influence: 1367.5] [Reference Citation Analysis]
128 Hu H, Lu X, Tao L, Bai B, Zhang Z, Chen Y, Zheng F, Chen J, Chen Z, Wang H. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice. Clin Vaccine Immunol 2007;14:894-901. [PMID: 17494640 DOI: 10.1128/CVI.00019-07] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
129 Cheng J, Zhao Y, Hu Y, Zhao J, Xue J, Zhang G. The furin-S2' site in avian coronavirus plays a key role in central nervous system damage progression. J Virol 2021:JVI. [PMID: 33727330 DOI: 10.1128/JVI.02447-20] [Reference Citation Analysis]
130 Zhang Y, Li T, Fu L, Yu C, Li Y, Xu X, Wang Y, Ning H, Zhang S, Chen W. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference. FEBS Lett. 2004;560:141-146. [PMID: 14988013 DOI: 10.1016/s0014-5793(04)00087-0] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 5.2] [Reference Citation Analysis]
131 Ataei M, Shirazi FM, Lamarine RJ, Nakhaee S, Mehrpour O. A double-edged sword of using opioids and COVID-19: a toxicological view. Subst Abuse Treat Prev Policy 2020;15:91. [PMID: 33272308 DOI: 10.1186/s13011-020-00333-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
132 Mehta SR, Sashindran VK, Kumar K, Gupta A. Severe Acute Respiratory Syndrome : An Update. Med J Armed Forces India 2007;63:52-5. [PMID: 27407939 DOI: 10.1016/S0377-1237(07)80110-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
133 Hu J, Wang J, Xu J, Li W, Han Y, Li Y, Ji J, Ye J, Xu Z, Zhang Z, Wei W, Li S, Wang J, Wang J, Yu J, Yang H. Evolution and variation of the SARS-CoV genome. Genomics Proteomics Bioinformatics 2003;1:216-25. [PMID: 15629034 DOI: 10.1016/s1672-0229(03)01027-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
134 Shih YP, Chen CY, Liu SJ, Chen KH, Lee YM, Chao YC, Chen YM. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus. J Virol 2006;80:10315-24. [PMID: 17041212 DOI: 10.1128/JVI.01138-06] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
135 Ding Z, Fang L, Yuan S, Zhao L, Wang X, Long S, Wang M, Wang D, Foda MF, Xiao S. The nucleocapsid proteins of mouse hepatitis virus and severe acute respiratory syndrome coronavirus share the same IFN-β antagonizing mechanism: attenuation of PACT-mediated RIG-I/ MDA5 activation. Oncotarget 2017;8:49655-70. [PMID: 28591694 DOI: 10.18632/oncotarget.17912] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
136 Stavrinides J, Guttman DS. Mosaic evolution of the severe acute respiratory syndrome coronavirus. J Virol 2004;78:76-82. [PMID: 14671089 DOI: 10.1128/jvi.78.1.76-82.2004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 74] [Article Influence: 6.1] [Reference Citation Analysis]
137 Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect 2012;65:477-89. [PMID: 23072791 DOI: 10.1016/j.jinf.2012.10.002] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 11.1] [Reference Citation Analysis]
138 Prentice E, McAuliffe J, Lu X, Subbarao K, Denison MR. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. J Virol 2004;78:9977-86. [PMID: 15331731 DOI: 10.1128/JVI.78.18.9977-9986.2004] [Cited by in Crossref: 176] [Cited by in F6Publishing: 159] [Article Influence: 9.8] [Reference Citation Analysis]
139 Bartlam M, Yang H, Rao Z. Structural insights into SARS coronavirus proteins. Curr Opin Struct Biol 2005;15:664-72. [PMID: 16263266 DOI: 10.1016/j.sbi.2005.10.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]
140 Serrano P, Almeida MS, Johnson MA, Wüthrich K. NMR assignment of the protein nsp3a from SARS-CoV. J Biomol NMR 2006;36 Suppl 1:45. [PMID: 16799860 DOI: 10.1007/s10858-006-9017-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
141 Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni EMT, Furlan R, Ciceri F, Rovere-Querini P;  COVID-19 BioB Outpatient Clinic Study group; Benedetti F. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594-600. [PMID: 32738287 DOI: 10.1016/j.bbi.2020.07.037] [Cited by in Crossref: 210] [Cited by in F6Publishing: 185] [Article Influence: 105.0] [Reference Citation Analysis]
142 Chan VS, Chan KY, Chen Y, Poon LL, Cheung AN, Zheng B, Chan KH, Mak W, Ngan HY, Xu X, Screaton G, Tam PK, Austyn JM, Chan LC, Yip SP, Peiris M, Khoo US, Lin CL. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet 2006;38:38-46. [PMID: 16369534 DOI: 10.1038/ng1698] [Cited by in Crossref: 99] [Cited by in F6Publishing: 96] [Article Influence: 5.8] [Reference Citation Analysis]
143 Liu IJ, Chen PJ, Yeh SH, Chiang YP, Huang LM, Chang MF, Chen SY, Yang PC, Chang SC, Wang WK; SARS Research Group of the National Taiwan University College of Medicine-National Taiwan University Hospital. Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS. J Clin Microbiol 2005;43:2444-8. [PMID: 15872279 DOI: 10.1128/JCM.43.5.2444-2448.2005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
144 Milewska A, Ciejka J, Kaminski K, Karewicz A, Bielska D, Zeglen S, Karolak W, Nowakowska M, Potempa J, Bosch BJ, Pyrc K, Szczubialka K. Novel polymeric inhibitors of HCoV-NL63. Antiviral Res 2013;97:112-21. [PMID: 23201315 DOI: 10.1016/j.antiviral.2012.11.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
145 Du L, Zhao G, Li L, He Y, Zhou Y, Zheng BJ, Jiang S. Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. Biochem Biophys Res Commun 2009;384:486-90. [PMID: 19422787 DOI: 10.1016/j.bbrc.2009.05.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
146 Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631-7. [PMID: 15141377 DOI: 10.1002/path.1570] [Reference Citation Analysis]
147 Wan Y, Shang J, Sun S, Tai W, Chen J, Geng Q, He L, Chen Y, Wu J, Shi Z, Zhou Y, Du L, Li F. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. J Virol 2020;94:e02015-19. [PMID: 31826992 DOI: 10.1128/JVI.02015-19] [Cited by in Crossref: 229] [Cited by in F6Publishing: 240] [Article Influence: 114.5] [Reference Citation Analysis]
148 Lassnig C, Sanchez CM, Egerbacher M, Walter I, Majer S, Kolbe T, Pallares P, Enjuanes L, Müller M. Development of a transgenic mouse model susceptible to human coronavirus 229E. Proc Natl Acad Sci U S A 2005;102:8275-80. [PMID: 15919828 DOI: 10.1073/pnas.0408589102] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
149 Zhan M. Civet Cats, Fried Grasshoppers, and David Beckham's Pajamas: Unruly Bodies after SARS. Am Anthropol 2005;107:31-42. [PMID: 32313270 DOI: 10.1525/aa.2005.107.1.031] [Cited by in Crossref: 62] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
150 Wong GW, Fok TF. Severe acute respiratory syndrome (SARS) in children. Pediatr Pulmonol Suppl 2004;26:69-71. [PMID: 15029602 DOI: 10.1002/ppul.70056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
151 Pandey K, Acharya A, Mohan M, Ng CL, Reid SP, Byrareddy SN. Animal models for SARS-CoV-2 research: A comprehensive literature review. Transbound Emerg Dis 2021;68:1868-85. [PMID: 33128861 DOI: 10.1111/tbed.13907] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
152 Foulongne V, Segondy M. Human bocavirus: a new respiratory pathogen? Future Virology 2007;2:173-81. [DOI: 10.2217/17460794.2.2.173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 Lee TW, Cherney MM, Huitema C, Liu J, James KE, Powers JC, Eltis LD, James MN. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. J Mol Biol 2005;353:1137-51. [PMID: 16219322 DOI: 10.1016/j.jmb.2005.09.004] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 6.2] [Reference Citation Analysis]
154 Law AH, Lee DC, Cheung BK, Yim HC, Lau AS. Role for nonstructural protein 1 of severe acute respiratory syndrome coronavirus in chemokine dysregulation. J Virol 2007;81:416-22. [PMID: 17035307 DOI: 10.1128/JVI.02336-05] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
155 Graham RL, Baric RS. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol 2010;84:3134-46. [PMID: 19906932 DOI: 10.1128/JVI.01394-09] [Cited by in Crossref: 369] [Cited by in F6Publishing: 265] [Article Influence: 28.4] [Reference Citation Analysis]
156 Eckstrand CD, Baldwin TJ, Rood KA, Clayton MJ, Lott JK, Wolking RM, Bradway DS, Baszler T. An outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms. PLoS Pathog 2021;17:e1009952. [PMID: 34767598 DOI: 10.1371/journal.ppat.1009952] [Reference Citation Analysis]
157 Zeng LP, Gao YT, Ge XY, Zhang Q, Peng C, Yang XL, Tan B, Chen J, Chmura AA, Daszak P, Shi ZL. Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response. J Virol 2016;90:6573-82. [PMID: 27170748 DOI: 10.1128/JVI.03079-15] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
158 Catalano-Pons C, Vallet C, Lebon P, Gendrel D. [Human bocavirus infections]. Med Mal Infect 2009;39:353-5. [PMID: 19062209 DOI: 10.1016/j.medmal.2008.10.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
159 Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun 2014;5:3067. [PMID: 24473083 DOI: 10.1038/ncomms4067] [Cited by in Crossref: 196] [Cited by in F6Publishing: 204] [Article Influence: 28.0] [Reference Citation Analysis]
160 Che XY, Qiu LW, Liao ZY, Wang YD, Wen K, Pan YX, Hao W, Mei YB, Cheng VC, Yuen KY. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. J Infect Dis 2005;191:2033-7. [PMID: 15897988 DOI: 10.1086/430355] [Cited by in Crossref: 113] [Cited by in F6Publishing: 98] [Article Influence: 6.6] [Reference Citation Analysis]
161 Guillén J, De Almeida RF, Prieto M, Villalaín J. Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes. Mol Membr Biol 2009;26:236-48. [PMID: 19412834 DOI: 10.1080/09687680902926203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
162 Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Jensenius JC, Turner MW, Peiris JS, Lau YL. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005;191:1697-704. [PMID: 15838797 DOI: 10.1086/429631] [Cited by in Crossref: 165] [Cited by in F6Publishing: 157] [Article Influence: 9.7] [Reference Citation Analysis]
163 Shuipys T, Montazeri N. Optimized Protocols for the Propagation and Quantification of Infectious Murine Hepatitis Virus (MHV-A59) Using NCTC Clone 1469 and 929 Cells. MPs 2022;5:5. [DOI: 10.3390/mps5010005] [Reference Citation Analysis]
164 Monto AS, DeJonge PM, Callear AP, Bazzi LA, Capriola SB, Malosh RE, Martin ET, Petrie JG. Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan. J Infect Dis 2020;222:9-16. [PMID: 32246136 DOI: 10.1093/infdis/jiaa161] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 33.0] [Reference Citation Analysis]
165 Li YH, Li J, Liu XE, Wang L, Li T, Zhou YH, Zhuang H. Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: comparison with results of other viral markers. J Virol Methods 2005;130:45-50. [PMID: 16024098 DOI: 10.1016/j.jviromet.2005.06.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
166 Roberts A, Wood J, Subbarao K, Ferguson M, Wood D, Cherian T. Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting 25-26 August 2005, London, UK. Vaccine 2006;24:7056-65. [PMID: 16930781 DOI: 10.1016/j.vaccine.2006.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
167 Ni L, Zhu J, Zhang J, Yan M, Gao GF, Tien P. Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain. Biochem Biophys Res Commun 2005;330:39-45. [PMID: 15781229 DOI: 10.1016/j.bbrc.2005.02.117] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
168 Roh C. A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide. Int J Nanomedicine 2012;7:2173-9. [PMID: 22619553 DOI: 10.2147/IJN.S31379] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
169 Nagata N, Iwata N, Hasegawa H, Fukushi S, Yokoyama M, Harashima A, Sato Y, Saijo M, Morikawa S, Sata T. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol 2007;81:1848-57. [PMID: 17151094 DOI: 10.1128/JVI.01967-06] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
170 Woo PC, Lau SK, Tsoi HW, Chan KH, Wong BH, Che XY, Tam VK, Tam SC, Cheng VC, Hung IF, Wong SS, Zheng BJ, Guan Y, Yuen KY. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 2004;363:841-5. [PMID: 15031027 DOI: 10.1016/S0140-6736(04)15729-2] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 5.7] [Reference Citation Analysis]
171 Geller C, Fontanay S, Mourer M, Dibama HM, Regnouf-de-Vains JB, Finance C, Duval RE. Antiseptic properties of two calix[4]arenes derivatives on the human coronavirus 229E. Antiviral Res 2010;88:343-6. [PMID: 20854844 DOI: 10.1016/j.antiviral.2010.09.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
172 Hu T, Zhang Y, Li L, Wang K, Chen S, Chen J, Ding J, Jiang H, Shen X. Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure. Virology 2009;388:324-34. [PMID: 19409595 DOI: 10.1016/j.virol.2009.03.034] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
173 Wu CY, Jan JT, Ma SH, Kuo CJ, Juan HF, Cheng YS, Hsu HH, Huang HC, Wu D, Brik A, Liang FS, Liu RS, Fang JM, Chen ST, Liang PH, Wong CH. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A 2004;101:10012-7. [PMID: 15226499 DOI: 10.1073/pnas.0403596101] [Cited by in Crossref: 279] [Cited by in F6Publishing: 268] [Article Influence: 15.5] [Reference Citation Analysis]
174 Pan R, Kindler E, Cao L, Zhou Y, Zhang Z, Liu Q, Ebert N, Züst R, Sun Y, Gorbalenya AE, Perlman S, Thiel V, Chen Y, Guo D. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition. mBio 2022;:e0366221. [PMID: 35073761 DOI: 10.1128/mbio.03662-21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
175 Yang C, Pan X, Huang Y, Cheng C, Xu X, Wu Y, Xu Y, Shang W, Niu X, Wan Y, Li Z, Zhang R, Liu S, Xiao G, Xu W. Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID-19 by Blocking SARS-CoV-2 Spike Protein-Mediated Membrane Fusion. Adv Ther (Weinh) 2021;:2000224. [PMID: 33786369 DOI: 10.1002/adtp.202000224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
176 Liu WK, Chen DH, Liu Q, Liang HX, Yang ZF, Qin S, Zhou R. Detection of human bocavirus from children and adults with acute respiratory tract illness in Guangzhou, southern China. BMC Infect Dis 2011;11:345. [PMID: 22168387 DOI: 10.1186/1471-2334-11-345] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
177 Yu F, Pan T, Huang F, Ying R, Liu J, Fan H, Zhang J, Liu W, Lin Y, Yuan Y, Yang T, Li R, Zhang X, Lv X, Chen Q, Liang A, Zou F, Liu B, Hu F, Tang X, Li L, Deng K, He X, Zhang H, Zhang Y, Ma X. Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L. Front Microbiol 2022;13:884034. [PMID: 35572668 DOI: 10.3389/fmicb.2022.884034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, Ng PC, Lam PW, Ho LC, To WW, Lai ST, Yan WW, Tan PY. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004;191:292-7. [PMID: 15295381 DOI: 10.1016/j.ajog.2003.11.019] [Cited by in Crossref: 572] [Cited by in F6Publishing: 458] [Article Influence: 31.8] [Reference Citation Analysis]
179 Chu LH, Choy WY, Tsai SN, Rao Z, Ngai SM. Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sci 2006;15:699-709. [PMID: 16600962 DOI: 10.1110/ps.052007306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
180 Arroliga AC, Diaz-Guzman E, Wiedemann HP. Severe acute respiratory syndrome, pulmonary function tests, and quality of life: lessons learned. Chest 2005;128:1088-9. [PMID: 16162688 DOI: 10.1378/chest.128.3.1088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
181 Severance EG, Dickerson FB, Viscidi RP, Bossis I, Stallings CR, Origoni AE, Sullens A, Yolken RH. Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr Bull 2011;37:101-7. [PMID: 19491313 DOI: 10.1093/schbul/sbp052] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 6.9] [Reference Citation Analysis]
182 Richard I, Robinson B, Dawson A, Aya A, Ali R. An Atypical Presentation of Fulminant Myocarditis Secondary to COVID-19 Infection. Cureus 2020;12:e9179. [PMID: 32802614 DOI: 10.7759/cureus.9179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
183 Yang J, Muhammad MH, Siddiqui MK, Hanif MF, Nasir M, Ali S, Liu J. Topological Co-indices of Hydroxyethyl Starch Conjugated with Hydroxychloroquine Used for COVID-19 Treatment. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2021.1996407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Shroff A, Nazarko TY. The Molecular Interplay between Human Coronaviruses and Autophagy. Cells 2021;10:2022. [PMID: 34440791 DOI: 10.3390/cells10082022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Pene F, Merlat A, Vabret A, Rozenberg F, Buzyn A, Dreyfus F, Cariou A, Freymuth F, Lebon P. Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis 2003;37:929-32. [PMID: 13130404 DOI: 10.1086/377612] [Cited by in Crossref: 173] [Cited by in F6Publishing: 151] [Article Influence: 9.1] [Reference Citation Analysis]
186 Gumanova NG, Gorshkov AU, Bogdanova NL, Korolev AI, Drapkina OM. Detection of Anti-SARS-CoV-2-S1 RBD-Specific Antibodies Prior to and during the Pandemic in 2011–2021 and COVID-19 Observational Study in 2019–2021. Vaccines 2022;10:581. [DOI: 10.3390/vaccines10040581] [Reference Citation Analysis]
187 Ye Q, Wang B, Zhang T, Xu J, Shang S. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. Am J Physiol Gastrointest Liver Physiol 2020;319:G245-52. [PMID: 32639848 DOI: 10.1152/ajpgi.00148.2020] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 35.0] [Reference Citation Analysis]
188 Chen Y, Chan VS, Zheng B, Chan KY, Xu X, To LY, Huang FP, Khoo US, Lin CL. A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. J Exp Med 2007;204:2529-36. [PMID: 17923501 DOI: 10.1084/jem.20070462] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
189 Schmidt ME, Varga SM. The CD8 T Cell Response to Respiratory Virus Infections. Front Immunol 2018;9:678. [PMID: 29686673 DOI: 10.3389/fimmu.2018.00678] [Cited by in Crossref: 129] [Cited by in F6Publishing: 127] [Article Influence: 32.3] [Reference Citation Analysis]
190 Tang X, Li G, Vasilakis N, Zhang Y, Shi Z, Zhong Y, Wang LF, Zhang S. Differential stepwise evolution of SARS coronavirus functional proteins in different host species. BMC Evol Biol 2009;9:52. [PMID: 19261195 DOI: 10.1186/1471-2148-9-52] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
191 Tan YJ, Fielding BC, Goh PY, Shen S, Tan TH, Lim SG, Hong W. Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J Virol 2004;78:14043-7. [PMID: 15564512 DOI: 10.1128/JVI.78.24.14043-14047.2004] [Cited by in Crossref: 148] [Article Influence: 8.2] [Reference Citation Analysis]
192 Al-sehemi AG, Pannipara M, Parulekar RS, Kilbile JT, Choudhari PB, Shaikh MH. In Silico Exploration of Binding Potentials of Anti SARS-CoV-1 Phytochemicals against Main Protease of SARS-CoV-2. Journal of Saudi Chemical Society 2022. [DOI: 10.1016/j.jscs.2022.101453] [Reference Citation Analysis]
193 Sun ZF, Meng XJ. Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis. J Clin Microbiol 2004;42:2351-2. [PMID: 15131233 DOI: 10.1128/JCM.42.5.2351-2352.2004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
194 Ivanov KA, Hertzig T, Rozanov M, Bayer S, Thiel V, Gorbalenya AE, Ziebuhr J. Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc Natl Acad Sci U S A 2004;101:12694-9. [PMID: 15304651 DOI: 10.1073/pnas.0403127101] [Cited by in Crossref: 191] [Cited by in F6Publishing: 181] [Article Influence: 10.6] [Reference Citation Analysis]
195 van der Hoek L, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF, Petersen G, Forster J, Berkhout B, Uberla K. Human coronavirus NL63 infection is associated with croup. Adv Exp Med Biol 2006;581:485-91. [PMID: 17037582 DOI: 10.1007/978-0-387-33012-9_86] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
196 Lam CM, Wong SF, Leung TN, Chow KM, Yu WC, Wong TY, Lai ST, Ho LC. A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome. BJOG 2004;111:771-4. [PMID: 15270922 DOI: 10.1111/j.1471-0528.2004.00199.x] [Cited by in Crossref: 158] [Cited by in F6Publishing: 142] [Article Influence: 8.8] [Reference Citation Analysis]
197 Bacha U, Barrila J, Gabelli SB, Kiso Y, Mario Amzel L, Freire E. Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro). Chem Biol Drug Des 2008;72:34-49. [PMID: 18611220 DOI: 10.1111/j.1747-0285.2008.00679.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
198 Pyrc K, Stożek K, Galan W, Potempa J. HexaPrime: a novel method for detection of coronaviruses. J Virol Methods 2013;188:29-36. [PMID: 23219933 DOI: 10.1016/j.jviromet.2012.11.039] [Reference Citation Analysis]
199 Chan KH, Yan MK, To KK, Lau SK, Woo PC, Cheng VC, Li WS, Chan JF, Tse H, Yuen KY. Use of the human colorectal adenocarcinoma (Caco-2) cell line for isolating respiratory viruses from nasopharyngeal aspirates. J Med Virol 2013;85:874-9. [PMID: 23508913 DOI: 10.1002/jmv.23538] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
200 Hozhabri H, Piceci Sparascio F, Sohrabi H, Mousavifar L, Roy R, Scribano D, De Luca A, Ambrosi C, Sarshar M. The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting. Int J Environ Res Public Health 2020;17:E5648. [PMID: 32764417 DOI: 10.3390/ijerph17165648] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
201 Zhou YM, Yang RQ, Tao SC, Li Z, Zhang Q, Gao HF, Zhang ZW, Du JY, Zhu PX, Ren LL, Zhang L, Wang D, Guo L, Wang YB, Guo Y, Zhang Y, Zhao CZ, Wang C, Jiang D, Liu YH, Yang HW, Rong L, Zhao YJ, An S, Li Z, Fan XD, Wang JW, Cheng Y, Liu O, Zheng Z, Zuo HC, Shan QZ, Ruan L, Lü ZX, Hung T, Cheng J. The design and application of DNA chips for early detection of SARS-CoV from clinical samples. J Clin Virol 2005;33:123-31. [PMID: 15911427 DOI: 10.1016/j.jcv.2004.10.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
202 Cui HJ, Tong XL, Li P, Hao YX, Chen XG, Li AG, Zhang ZY, Duan J, Zhen M, Zhang B, Hua CJ, Gong YW. Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: Retrospective analysis. World J Gastroenterol 2004; 10(11): 1652-1655 [PMID: 15162543 DOI: 10.3748/wjg.v10.i11.1652] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
203 Yang Y, Peng F, Wang R, Yange M, Guan K, Jiang T, Xu G, Sun J, Chang C. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun. 2020;109:102434. [PMID: 32143990 DOI: 10.1016/j.jaut.2020.102434] [Cited by in Crossref: 349] [Cited by in F6Publishing: 269] [Article Influence: 174.5] [Reference Citation Analysis]
204 Yang LT, Peng H, Zhu ZL, Li G, Huang ZT, Zhao ZX, Koup RA, Bailer RT, Wu CY. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. Clin Immunol. 2006;120:171-178. [PMID: 16781892 DOI: 10.1016/j.clim.2006.05.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 5.2] [Reference Citation Analysis]
205 Lai CW, Chung YC, Lai YK, Chang MD, Hu YC. Expression and purification of N and E proteins from severe acute respiratory syndrome (SARS)-associated coronavirus: a comparative study. Biotechnol Lett 2005;27:883-91. [PMID: 16091881 DOI: 10.1007/s10529-005-7176-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
206 Lawrence Panchali MJ, Oh HJ, Lee YM, Kim CM, Tariq M, Seo JW, Kim DY, Yun NR, Kim DM. Accuracy of Real-Time Polymerase Chain Reaction in COVID-19 Patients. Microbiol Spectr 2022;:e0059121. [PMID: 35170995 DOI: 10.1128/spectrum.00591-21] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
207 Kiselevskiy M, Shubina I, Chikileva I, Sitdikova S, Samoylenko I, Anisimova N, Kirgizov K, Suleimanova A, Gorbunova T, Varfolomeeva S. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence? Pharmaceuticals (Basel) 2020;13:E166. [PMID: 32722596 DOI: 10.3390/ph13080166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
208 Xie Q, He X, Yang F, Liu X, Li Y, Liu Y, Yang Z, Yu J, Zhang B, Zhao W. Analysis of the Genome Sequence and Prediction of B-Cell Epitopes of the Envelope Protein of Middle East Respiratory Syndrome-Coronavirus. IEEE/ACM Trans Comput Biol Bioinform 2018;15:1344-50. [PMID: 28574363 DOI: 10.1109/TCBB.2017.2702588] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
209 Alvarez E, DeDiego ML, Nieto-Torres JL, Jiménez-Guardeño JM, Marcos-Villar L, Enjuanes L. The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated. Virology 2010;402:281-91. [PMID: 20409569 DOI: 10.1016/j.virol.2010.03.015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
210 Peng H, Yang LT, Wang LY, Li J, Huang J, Lu ZQ, Koup RA, Bailer RT, Wu CY. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 2006;351:466-75. [PMID: 16690096 DOI: 10.1016/j.virol.2006.03.036] [Cited by in Crossref: 103] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
211 Guruprasad L. Human coronavirus spike protein-host receptor recognition. Prog Biophys Mol Biol 2021;161:39-53. [PMID: 33137344 DOI: 10.1016/j.pbiomolbio.2020.10.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
212 Wu D, Tu C, Xin C, Xuan H, Meng Q, Liu Y, Yu Y, Guan Y, Jiang Y, Yin X, Crameri G, Wang M, Li C, Liu S, Liao M, Feng L, Xiang H, Sun J, Chen J, Sun Y, Gu S, Liu N, Fu D, Eaton BT, Wang LF, Kong X. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J Virol 2005;79:2620-5. [PMID: 15681462 DOI: 10.1128/JVI.79.4.2620-2625.2005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 62] [Article Influence: 4.9] [Reference Citation Analysis]
213 Ngan Kee WD, Leung TN. Severe acute respiratory syndrome (SARS). Int J Obstet Anesth 2003;12:151-2. [PMID: 15321475 DOI: 10.1016/S0959-289X(03)00061-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
214 Chan WM, Yuen KS, Fan DS, Lam DS, Chan PK, Sung JJ. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br J Ophthalmol 2004;88:968-9. [PMID: 15205249 DOI: 10.1136/bjo.2003.039461] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
215 Woo PC, Wong BH, Huang Y, Lau SK, Yuen KY. Cytosine deamination and selection of CpG suppressed clones are the two major independent biological forces that shape codon usage bias in coronaviruses. Virology 2007;369:431-42. [PMID: 17881030 DOI: 10.1016/j.virol.2007.08.010] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
216 Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, Faure P, Akhavan P, Low DE, Kain KC. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2005;191:193-197. [PMID: 15609228 DOI: 10.1086/426870] [Cited by in Crossref: 104] [Cited by in F6Publishing: 90] [Article Influence: 5.8] [Reference Citation Analysis]
217 Nelli RK, Phadke KS, Castillo G, Yen L, Saunders A, Rauh R, Nelson W, Bellaire BH, Giménez-Lirola LG. Enhanced apoptosis as a possible mechanism to self-limit SARS-CoV-2 replication in porcine primary respiratory epithelial cells in contrast to human cells. Cell Death Discov 2021;7:383. [PMID: 34893585 DOI: 10.1038/s41420-021-00781-w] [Reference Citation Analysis]
218 Bahrami A, Ferns GA. Genetic and pathogenic characterization of SARS-CoV-2: a review. Future Virology 2020;15:533-49. [DOI: 10.2217/fvl-2020-0129] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
219 Finkbeiner S, Wang D. New Virus Discovery in the 21st Century. In: Persing DH, Tenover FC, Tang Y, Nolle FS, Hayden RT, van Belkum A, editors. Molecular Microbiology. Wiley; 2011. pp. 641-52. [DOI: 10.1128/9781555816834.ch41] [Reference Citation Analysis]
220 Miura TA, Holmes KV. Host-pathogen interactions during coronavirus infection of primary alveolar epithelial cells. J Leukoc Biol 2009;86:1145-51. [PMID: 19638499 DOI: 10.1189/jlb.0209078] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
221 Guan M, Chen HY, Tan PH, Shen S, Goh PY, Tan YJ, Pang PH, Lu Y, Fong PY, Chin D. Use of viral lysate antigen combined with recombinant protein in Western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome. Clin Diagn Lab Immunol 2004;11:1148-53. [PMID: 15539520 DOI: 10.1128/CDLI.11.6.1148-1153.2004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
222 Meltzer MI. Multiple contact dates and SARS incubation periods. Emerg Infect Dis 2004;10:207-9. [PMID: 15030684 DOI: 10.3201/eid1002.030426] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
223 Lu Q, Wang Z, Yin Y, Zhao Y, Tao P, Zhong P. Association of Peripheral Lymphocyte and the Subset Levels With the Progression and Mortality of COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2020;7:558545. [PMID: 33102499 DOI: 10.3389/fmed.2020.558545] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
224 Ng MW, Zhou G, Chong WP, Lee LW, Law HK, Zhang H, Wong WH, Fok SF, Zhai Y, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Peiris JS, He F, Lau YL. The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. BMC Infect Dis 2007;7:50. [PMID: 17540042 DOI: 10.1186/1471-2334-7-50] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
225 Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Clinical features of probable severe acute respiratory syndrome in Beijing. World J Gastroenterol 2005; 11(19): 2971-2974 [PMID: 15902739 DOI: 10.3748/wjg.v11.i19.2971] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
226 Muhammad YA. Reconciling differences pertaining to the origin of SARS-CoV-2. Bull Natl Res Cent 2022;46:28. [PMID: 35153468 DOI: 10.1186/s42269-022-00712-4] [Reference Citation Analysis]
227 Rohaim MA, Clayton E, Sahin I, Vilela J, Khalifa ME, Al-Natour MQ, Bayoumi M, Poirier AC, Branavan M, Tharmakulasingam M, Chaudhry NS, Sodi R, Brown A, Burkhart P, Hacking W, Botham J, Boyce J, Wilkinson H, Williams C, Whittingham-Dowd J, Shaw E, Hodges M, Butler L, Bates MD, La Ragione R, Balachandran W, Fernando A, Munir M. Artificial Intelligence-Assisted Loop Mediated Isothermal Amplification (AI-LAMP) for Rapid Detection of SARS-CoV-2. Viruses 2020;12:E972. [PMID: 32883050 DOI: 10.3390/v12090972] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
228 Deshwal V, Kumar V. Study of Coronavirus Disease (COVID-19) Outbreak in India. TONURSJ 2021;15:62-73. [DOI: 10.2174/1874434602115010062] [Reference Citation Analysis]
229 Cui W, Ouyang T, Qiu Y, Cui D. Literature Review of the Implications of Exercise Rehabilitation Strategies for SARS Patients on the Recovery of COVID-19 Patients. Healthcare (Basel) 2021;9:590. [PMID: 34070115 DOI: 10.3390/healthcare9050590] [Reference Citation Analysis]
230 Asghari A, Wang C, Yoo KM, Rostamian A, Xu X, Shin JD, Dalir H, Chen RT. Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges. Appl Phys Rev 2021;8:031313. [PMID: 34552683 DOI: 10.1063/5.0022211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
231 Huynh A, Bruhn A, Browne B. A Review of Catastrophic Risks for Life Insurers: Catastrophic Risks for Life Insurers. Risk Management and Insurance Review 2013;16:233-66. [DOI: 10.1111/rmir.12011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
232 Wei WI, Ho WK. Severe acute respiratory syndrome: what have we learned. Adv Surg 2005;39:343-54. [PMID: 16250560 DOI: 10.1016/j.yasu.2005.04.001] [Reference Citation Analysis]
233 Ma Y, Wu L, Shaw N, Gao Y, Wang J, Sun Y, Lou Z, Yan L, Zhang R, Rao Z. Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex. Proc Natl Acad Sci U S A 2015;112:9436-41. [PMID: 26159422 DOI: 10.1073/pnas.1508686112] [Cited by in Crossref: 224] [Cited by in F6Publishing: 180] [Article Influence: 32.0] [Reference Citation Analysis]
234 Geller C, Fontanay S, Finance C, Duval RE. A new Sephadex-based method for removing microbicidal and cytotoxic residues when testing antiseptics against viruses: Experiments with a human coronavirus as a model. J Virol Methods. 2009;159:217-226. [PMID: 19490977 DOI: 10.1016/j.jviromet.2009.03.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
235 Wang ZG, Zheng ZH, Shang L, Li LJ, Cong LM, Feng MG, Luo Y, Cheng SY, Zhang YJ, Ru MG, Wang ZX, Bao QY. Molecular evolution and multilocus sequence typing of 145 strains of SARS-CoV. FEBS Lett 2005;579:4928-36. [PMID: 16112670 DOI: 10.1016/j.febslet.2005.07.075] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
236 Lai TS, Yu WC. The lessons of SARS in Hong Kong. Clin Med (Lond) 2010;10:50-3. [PMID: 20408308 DOI: 10.7861/clinmedicine.10-1-50] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
237 Chuck CP, Chow HF, Wan DC, Wong KB. Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses. PLoS One. 2011;6:e27228. [PMID: 22073294 DOI: 10.1371/journal.pone.0027228] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
238 Che XY, Qiu LW, Pan YX, Wen K, Hao W, Zhang LY, Wang YD, Liao ZY, Hua X, Cheng VC, Yuen KY. Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J Clin Microbiol 2004;42:2629-35. [PMID: 15184444 DOI: 10.1128/JCM.42.6.2629-2635.2004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 62] [Article Influence: 4.3] [Reference Citation Analysis]
239 Roychoudhury S, Das A, Jha NK, Kesari KK, Roychoudhury S, Jha SK, Kosgi R, Choudhury AP, Lukac N, Madhu NR, Kumar D, Slama P. Viral pathogenesis of SARS-CoV-2 infection and male reproductive health. Open Biol 2021;11:200347. [PMID: 33465325 DOI: 10.1098/rsob.200347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
240 Poon LL, Chan KH, Wong OK, Cheung TK, Ng I, Zheng B, Seto WH, Yuen KY, Guan Y, Peiris JS. Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin Chem 2004;50:67-72. [PMID: 14709637 DOI: 10.1373/clinchem.2003.023663] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 5.3] [Reference Citation Analysis]
241 Morris JG Jr, Greenspan A, Howell K, Gargano LM, Mitchell J, Jones JL, Potter M, Isakov A, Woods C, Hughes JM. Southeastern Center for Emerging Biologic Threats tabletop exercise: foodborne toxoplasmosis outbreak on college campuses. Biosecur Bioterror 2012;10:89-97. [PMID: 22283568 DOI: 10.1089/bsp.2011.0040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
242 Chen W, Yan M, Yang L, Ding B, He B, Wang Y, Liu X, Liu C, Zhu H, You B, Huang S, Zhang J, Mu F, Xiang Z, Feng X, Wen J, Fang J, Yu J, Yang H, Wang J. SARS-associated coronavirus transmitted from human to pig. Emerg Infect Dis 2005;11:446-8. [PMID: 15757562 DOI: 10.3201/eid1103.040824] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
243 Hsueh PR, Huang LM, Chen PJ, Kao CL, Yang PC. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect 2004;10:1062-6. [PMID: 15606632 DOI: 10.1111/j.1469-0691.2004.01009.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 143] [Article Influence: 9.4] [Reference Citation Analysis]
244 Benzigar MR, Bhattacharjee R, Baharfar M, Liu G. Current methods for diagnosis of human coronaviruses: pros and cons. Anal Bioanal Chem 2021;413:2311-30. [PMID: 33219449 DOI: 10.1007/s00216-020-03046-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
245 Nomura R, Kiyota A, Suzaki E, Kataoka K, Ohe Y, Miyamoto K, Senda T, Fujimoto T. Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. J Virol 2004;78:8701-8. [PMID: 15280478 DOI: 10.1128/JVI.78.16.8701-8708.2004] [Cited by in Crossref: 117] [Cited by in F6Publishing: 94] [Article Influence: 6.5] [Reference Citation Analysis]
246 Sampath R, Hall TA, Massire C, Li F, Blyn LB, Eshoo MW, Hofstadler SA, Ecker DJ. Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Ann N Y Acad Sci 2007;1102:109-20. [PMID: 17470915 DOI: 10.1196/annals.1408.008] [Cited by in Crossref: 81] [Cited by in F6Publishing: 69] [Article Influence: 5.4] [Reference Citation Analysis]
247 Chan KK, Dorosky D, Sharma P, Abbasi SA, Dye JM, Kranz DM, Herbert AS, Procko E. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science 2020;369:1261-5. [PMID: 32753553 DOI: 10.1126/science.abc0870] [Cited by in Crossref: 180] [Cited by in F6Publishing: 156] [Article Influence: 90.0] [Reference Citation Analysis]
248 Moal V, Zandotti C, Colson P. Emerging viral diseases in kidney transplant recipients. Rev Med Virol 2013;23:50-69. [PMID: 23132728 DOI: 10.1002/rmv.1732] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
249 Rauf A, Ishtiaq M, Siddiqui MK. Topological Study of Hydroxychloroquine Conjugated Molecular Structure Used for Novel Coronavirus (COVID-19) Treatment. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2021.1873807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
250 Chan BC, Lee CP, Tang GW. Universal SARS preventive measures in an obstetrics unit: experience of health care staff. Am J Infect Control 2004;32:417-20. [PMID: 15525918 DOI: 10.1016/j.ajic.2004.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
251 Fan S, Yan S, Liu X, Liu P, Huang L, Wang S. Human Coronavirus Infections and Pregnancy. Matern Fetal Med 2021;3:53-65. [PMID: 34192279 DOI: 10.1097/FM9.0000000000000071] [Reference Citation Analysis]
252 Wang Y, Yan J, Shi Y, Li P, Liu C, Ma Q, Yang R, Wang X, Zhu L, Yang X, Cao C. Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection. BMC Infect Dis 2009;9:51. [PMID: 19405982 DOI: 10.1186/1471-2334-9-51] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
253 de Lang A, Osterhaus AD, Haagmans BL. Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. Virology 2006;353:474-81. [PMID: 16860835 DOI: 10.1016/j.virol.2006.06.011] [Cited by in Crossref: 82] [Cited by in F6Publishing: 83] [Article Influence: 5.1] [Reference Citation Analysis]
254 Vu HT, Leitmeyer KC, Le DH, Miller MJ, Nguyen QH, Uyeki TM, Reynolds MG, Aagesen J, Nicholson KG, Vu QH, Bach HA, Plan AJ. Clinical description of a completed outbreak of SARS in Vietnam, February-May 2003. Emerg Infect Dis 2004;10:334-8. [PMID: 15030707 DOI: 10.3201/eid1002.030761] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
255 Zhao J, Zhou H, Huang W, Zhou J, Qiu M, Deng Z, Chen L, Weng Y, Cai L, Gu Y, Zheng Q, Chen Q, Hou X, Wang L, Shen L, Yang Z. Cell morphological analysis of SARS-CoV-2 infection by transmission electron microscopy. J Thorac Dis 2020;12:4368-73. [PMID: 32944349 DOI: 10.21037/jtd-20-1368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
256 Chang HL, Chen KT, Lai SK, Kuo HW, Su IJ, Lin RS, Sung FC. Hematological and biochemical factors predicting SARS fatality in Taiwan. J Formos Med Assoc. 2006;105:439-450. [PMID: 16801031 DOI: 10.1016/s0929-6646(09)60183-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
257 Hu MC, Jones T, Kenney RT, Barnard DL, Burt DS, Lowell GH. Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice. Vaccine 2007;25:6334-40. [PMID: 17640780 DOI: 10.1016/j.vaccine.2007.06.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
258 Wang Y, Shan BJ, Shen XB, Zheng CC, Wang JQ, Li GL, Pan YY. Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer. Cancer Manag Res 2020;12:12021-8. [PMID: 33262652 DOI: 10.2147/CMAR.S279564] [Reference Citation Analysis]
259 Leung TF, Wong GW, Hon KL, Fok TF. Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management. Paediatr Respir Rev 2003;4:334-9. [PMID: 14629957 DOI: 10.1016/s1526-0542(03)00088-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
260 Zhou Y, Chen L. Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis. Int J Environ Res Public Health 2020;17:E3082. [PMID: 32354181 DOI: 10.3390/ijerph17093082] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
261 Alghamdi S, Barakat B, Berrou I, Alzahrani A, Haseeb A, Hammad MA, Anwar S, Sindi AAA, Almasmoum HA, Albanghali M. Clinical Efficacy of Hydroxychloroquine in Patients with COVID-19: Findings from an Observational Comparative Study in Saudi Arabia. Antibiotics (Basel) 2021;10:365. [PMID: 33807320 DOI: 10.3390/antibiotics10040365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
262 Ziebuhr J. SARS--unprecedented global response to a newly emerging disease. Int J Med Microbiol 2003;293:229-31. [PMID: 14503787 DOI: 10.1078/1438-4221-00270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
263 Mykytyn AZ, Breugem TI, Riesebosch S, Schipper D, van den Doel PB, Rottier RJ, Lamers MM, Haagmans BL. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. Elife 2021;10:e64508. [PMID: 33393462 DOI: 10.7554/eLife.64508] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 28.0] [Reference Citation Analysis]
264 Möhn N, Pul R, Kleinschnitz C, Prüss H, Witte T, Stangel M, Skripuletz T. Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS. Front Immunol 2020;11:1059. [PMID: 32477373 DOI: 10.3389/fimmu.2020.01059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
265 Supekar VM, Bruckmann C, Ingallinella P, Bianchi E, Pessi A, Carfí A. Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein. Proc Natl Acad Sci USA. 2004;101:17958-17963. [PMID: 15604146 DOI: 10.1073/pnas.0406128102] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
266 Cheng WC, Huang JC, Liou CY. Segmentation of DNA using simple recurrent neural network. Knowl Based Syst 2012;26:271-80. [PMID: 32288315 DOI: 10.1016/j.knosys.2011.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
267 Hui DS. Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome). Clin Chest Med 2017;38:71-86. [PMID: 28159163 DOI: 10.1016/j.ccm.2016.11.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 12.5] [Reference Citation Analysis]
268 Okada M, Takemoto Y, Okuno Y, Hashimoto S, Yoshida S, Fukunaga Y, Tanaka T, Kita Y, Kuwayama S, Muraki Y, Kanamaru N, Takai H, Okada C, Sakaguchi Y, Furukawa I, Yamada K, Matsumoto M, Kase T, Demello DE, Peiris JS, Chen PJ, Yamamoto N, Yoshinaka Y, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M. The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice. Vaccine 2005;23:2269-72. [PMID: 15755609 DOI: 10.1016/j.vaccine.2005.01.036] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
269 Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, Cottrell CA, Becker MM, Wang L, Shi W, Kong WP, Andres EL, Kettenbach AN, Denison MR, Chappell JD, Graham BS, Ward AB, McLellan JS. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A 2017;114:E7348-57. [PMID: 28807998 DOI: 10.1073/pnas.1707304114] [Cited by in Crossref: 469] [Cited by in F6Publishing: 414] [Article Influence: 93.8] [Reference Citation Analysis]
270 Niu X, Kong F, Xu J, Liu M, Wang Q. Mutations in Porcine Epidemic Diarrhea Virus nsp1 Cause Increased Viral Sensitivity to Host Interferon Responses and Attenuation In Vivo. J Virol 2022;:e0046922. [PMID: 35583324 DOI: 10.1128/jvi.00469-22] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Kuiken T, van den Hoogen BG, van Riel DA, Laman JD, van Amerongen G, Sprong L, Fouchier RA, Osterhaus AD. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol 2004;164:1893-900. [PMID: 15161626 DOI: 10.1016/S0002-9440(10)63750-9] [Cited by in Crossref: 111] [Cited by in F6Publishing: 48] [Article Influence: 6.2] [Reference Citation Analysis]
272 He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology 2005;334:74-82. [PMID: 15749124 DOI: 10.1016/j.virol.2005.01.034] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 4.9] [Reference Citation Analysis]
273 Shao H, Lan D, Duan Z, Liu Z, Min J, Zhang L, Huang J, Su J, Chen S, Xu A. Upregulation of mitochondrial gene expression in PBMC from convalescent SARS patients. J Clin Immunol 2006;26:546-54. [PMID: 17024565 DOI: 10.1007/s10875-006-9046-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
274 Han YJ, Lee KH, Yoon S, Nam SW, Ryu S, Seong D, Kim JS, Lee JY, Yang JW, Lee J, Koyanagi A, Hong SH, Dragioti E, Radua J, Smith L, Oh H, Ghayda RA, Kronbichler A, Effenberger M, Kresse D, Denicolò S, Kang W, Jacob L, Shin H, Shin JI. Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials. Theranostics 2021;11:1207-31. [PMID: 33391531 DOI: 10.7150/thno.48342] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
275 Roh C, Jo SK. Quantitative and sensitive detection of SARS coronavirus nucleocapsid protein using quantum dots-conjugated RNA aptamer on chip. J Chem Technol Biotechnol 2011;86:1475-9. [PMID: 32336860 DOI: 10.1002/jctb.2721] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
276 Quan PL, Firth C, Street C, Henriquez JA, Petrosov A, Tashmukhamedova A, Hutchison SK, Egholm M, Osinubi MO, Niezgoda M, Ogunkoya AB, Briese T, Rupprecht CE, Lipkin WI. Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria. mBio 2010;1:e00208-10. [PMID: 21063474 DOI: 10.1128/mBio.00208-10] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 7.0] [Reference Citation Analysis]
277 Zhai J, Briese T, Dai E, Wang X, pang X, Du Z, Liu H, Wang J, Wang H, Guo Z, Chen Z, Jiang L, Zhou D, Han Y, Jabado O, Palacios G, Lipkin WI, Tang R. Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003. Emerg Infect Dis 2004;10:300-3. [PMID: 15030701 DOI: 10.3201/eid1002.030799] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
278 Lau SKP, Wong ACP, Zhang L, Luk HKH, Kwok JSL, Ahmed SS, Cai JP, Zhao PSH, Teng JLL, Tsui SKW, Yuen KY, Woo PCY. Novel Bat Alphacoronaviruses in Southern China Support Chinese Horseshoe Bats as an Important Reservoir for Potential Novel Coronaviruses. Viruses 2019;11:E423. [PMID: 31067830 DOI: 10.3390/v11050423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
279 Lipkin WI, Palacios G, Briese T. Diagnostics and discovery in viral hemorrhagic fevers. Ann N Y Acad Sci 2009;1171 Suppl 1:E6-11. [PMID: 19751404 DOI: 10.1111/j.1749-6632.2009.05056.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
280 Kandeel M, Al-Nazawi M. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sci. 2020;251:117627. [PMID: 32251634 DOI: 10.1016/j.lfs.2020.117627] [Cited by in Crossref: 153] [Cited by in F6Publishing: 132] [Article Influence: 76.5] [Reference Citation Analysis]
281 Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Zhang Y, Chan KH, Tsoi HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li L, Yuen KY. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013;381:1916-25. [PMID: 23623390 DOI: 10.1016/S0140-6736(13)60903-4] [Cited by in Crossref: 608] [Cited by in F6Publishing: 372] [Article Influence: 67.6] [Reference Citation Analysis]
282 Dong BQ, Liu W, Fan XH, Vijaykrishna D, Tang XC, Gao F, Li LF, Li GJ, Zhang JX, Yang LQ, Poon LL, Zhang SY, Peiris JS, Smith GJ, Chen H, Guan Y. Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China. J Virol 2007;81:6920-6. [PMID: 17459938 DOI: 10.1128/JVI.00299-07] [Cited by in Crossref: 92] [Cited by in F6Publishing: 69] [Article Influence: 6.1] [Reference Citation Analysis]
283 Schneider M, Ackermann K, Stuart M, Wex C, Protzer U, Schätzl HM, Gilch S. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain. J Virol 2012;86:10112-22. [PMID: 22787216 DOI: 10.1128/JVI.01001-12] [Cited by in Crossref: 82] [Cited by in F6Publishing: 60] [Article Influence: 8.2] [Reference Citation Analysis]
284 Chen YM, Liang SY, Shih YP, Chen CY, Lee YM, Chang L, Jung SY, Ho MS, Liang KY, Chen HY, Chan YJ, Chu DC. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol. 2006;44:359-365. [PMID: 16455884 DOI: 10.1128/jcm.44.2.359-365.2006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
285 McBride R, Fielding BC. The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis. Viruses 2012;4:2902-23. [PMID: 23202509 DOI: 10.3390/v4112902] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 7.4] [Reference Citation Analysis]
286 Sampathkumar P, Temesgen Z, Smith TF, Thompson RL. SARS: epidemiology, clinical presentation, management, and infection control measures. Mayo Clin Proc 2003;78:882-90. [PMID: 12839084 DOI: 10.4065/78.7.882] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
287 Moriyama Y, Hamada H, Okada M, Tsuchiya N, Maru H, Shirato Y, Maeda Y, Hirose Y, Yoshida M, Omura Y, Honda T, Muto A, Hayashi K, Terai M. Distinctive clinical features of human bocavirus in children younger than 2 years. Eur J Pediatr 2010;169:1087-92. [PMID: 20383526 DOI: 10.1007/s00431-010-1183-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
288 Liu L, Fang Q, Deng F, Wang H, Yi CE, Ba L, Yu W, Lin RD, Li T, Hu Z, Ho DD, Zhang L, Chen Z. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. J Virol 2007;81:4694-700. [PMID: 17314167 DOI: 10.1128/JVI.02389-06] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
289 Chen S, Chen LL, Luo HB, Sun T, Chen J, Ye F, Cai JH, Shen JK, Shen X, Jiang HL. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique. Acta Pharmacol Sin 2005;26:99-106. [PMID: 15659121 DOI: 10.1111/j.1745-7254.2005.00010.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
290 Lateef F. SARS changes the ED paradigm. Am J Emerg Med 2004;22:483-7. [PMID: 15520944 DOI: 10.1016/j.ajem.2004.07.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
291 Candel FJ, Viñuela-Prieto JM, González Del Castillo J, Barreiro García P, Fragiel Saavedra M, Hernández Píriz A, Jiménez Virumbrales D, Canora Lebrato J, García de Casasola G, Gil Prieto R, San-Román Montero J, Ortega Anselmi J, Barba Martín R, Prados Roa F, Marco Martínez J, Zapatero Gaviria A. Utility of lateral flow tests in SARS-CoV-2 infection monitorization. Rev Esp Quimioter 2020;33:258-66. [PMID: 32492991 DOI: 10.37201/req/052.2020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
292 Lau SK, Che XY, Woo PC, Wong BH, Cheng VC, Woo GK, Hung IF, Poon RW, Chan KH, Peiris JS, Yuen KY. SARS coronavirus detection methods. Emerg Infect Dis 2005;11:1108-11. [PMID: 16022791 DOI: 10.3201/eid1107.041045] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
293 Timani KA, Liao Q, Ye L, Zeng Y, Liu J, Zheng Y, Ye L, Yang X, Lingbao K, Gao J, Zhu Y. Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Res 2005;114:23-34. [PMID: 15992957 DOI: 10.1016/j.virusres.2005.05.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 3.5] [Reference Citation Analysis]
294 Wang F, Lai CX, Huang PY, Liu JM, Wang XF, Tang QY, Zhou X, Xian WJ, Chen RK, Li X, Li ZY, Liao LQ, He Q, Liu L. Comparison of Clinical Characteristics and Outcomes of Pediatric and Adult Patients with Coronavirus Disease 2019 in Shenzhen, China. Biomed Environ Sci 2020;33:906-15. [PMID: 33472730 DOI: 10.3967/bes2020.124] [Reference Citation Analysis]
295 Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004;323:264-268. [PMID: 15351731 DOI: 10.1016/j.bbrc.2004.08.085] [Cited by in Crossref: 376] [Cited by in F6Publishing: 346] [Article Influence: 20.9] [Reference Citation Analysis]
296 Bárcena M, Oostergetel GT, Bartelink W, Faas FG, Verkleij A, Rottier PJ, Koster AJ, Bosch BJ. Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A 2009;106:582-7. [PMID: 19124777 DOI: 10.1073/pnas.0805270106] [Cited by in Crossref: 140] [Cited by in F6Publishing: 121] [Article Influence: 10.8] [Reference Citation Analysis]
297 Hui DS, Sung JJ. Severe acute respiratory syndrome. Chest 2003;124:12-5. [PMID: 12853495 DOI: 10.1378/chest.124.1.12] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
298 Afzal A, Iqbal N, Feroz S, Ali A, Ehsan MA, Khan SA, Rehman A. Rapid antibody diagnostics for SARS-CoV-2 adaptive immune response. Anal Methods 2021;13:4019-37. [PMID: 34555136 DOI: 10.1039/d1ay00888a] [Reference Citation Analysis]
299 Liu J, Xie W, Wang Y, Xiong Y, Chen S, Han J, Wu Q. A comparative overview of COVID-19, MERS and SARS: Review article. Int J Surg 2020;81:1-8. [PMID: 32730205 DOI: 10.1016/j.ijsu.2020.07.032] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
300 Li F. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. J Virol 2008;82:6984-91. [PMID: 18448527 DOI: 10.1128/JVI.00442-08] [Cited by in Crossref: 120] [Cited by in F6Publishing: 71] [Article Influence: 8.6] [Reference Citation Analysis]
301 Hu X, Deng Y, Wang J, Li H, Li M, Lu Z. Short term outcome and risk factors for mortality in adults with critical severe acute respiratory syndrome (SARS). J Huazhong Univ Sci Technolog Med Sci. 2004;24:514-517. [PMID: 15641708 DOI: 10.1007/bf02831124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
302 Maunder R. The experience of the 2003 SARS outbreak as a traumatic stress among frontline healthcare workers in Toronto: lessons learned. Philos Trans R Soc Lond B Biol Sci 2004;359:1117-25. [PMID: 15306398 DOI: 10.1098/rstb.2004.1483] [Cited by in Crossref: 164] [Cited by in F6Publishing: 149] [Article Influence: 9.1] [Reference Citation Analysis]
303 Wei P, Cai Z, Hua J, Yu W, Chen J, Kang K, Qiu C, Ye L, Hu J, Ji K. Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9. Biomed Res Int 2016;2016:5717108. [PMID: 27525272 DOI: 10.1155/2016/5717108] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
304 Rebendenne A, Valadão ALC, Tauziet M, Maarifi G, Bonaventure B, McKellar J, Planès R, Nisole S, Arnaud-Arnould M, Moncorgé O, Goujon C. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J Virol 2021:JVI. [PMID: 33514628 DOI: 10.1128/JVI.02415-20] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 29.0] [Reference Citation Analysis]
305 Suwannarach N, Kumla J, Sujarit K, Pattananandecha T, Saenjum C, Lumyong S. Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses. Molecules 2020;25:E1800. [PMID: 32295300 DOI: 10.3390/molecules25081800] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
306 Li RW, Leung KW, Sun FC, Samaranayake LP. Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I : Epidemiology, virology, pathology and general health issues. Br Dent J 2004;197:77-80. [PMID: 15272339 DOI: 10.1038/sj.bdj.4811469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
307 Wang XW, Li JS, Guo TK, Zhen B, Kong QX, Yi B, Li Z, Song N, Jin M, Wu XM, Xiao WJ, Zhu XM, Gu CQ, Yin J, Wei W, Yao W, Liu C, Li JF, Ou GR, Wang MN, Fang TY, Wang GJ, Qiu YH, Wu HH, Chao FH, Li JW. Excretion and detection of SARS coronavirus and its nucleic acid from digestive system. World J Gastroenterol 2005; 11(28): 4390-4395 [PMID: 16038039 DOI: 10.3748/wjg.v11.i28.4390] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
308 Lai CW, Chan ZR, Yang DG, Lo WH, Lai YK, Chang MD, Hu YC. Accelerated induction of apoptosis in insect cells by baculovirus-expressed SARS-CoV membrane protein. FEBS Lett 2006;580:3829-34. [PMID: 16797548 DOI: 10.1016/j.febslet.2006.06.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
309 Mustafin RN, Khusnutdinova EK. COVID-19, Retroelements, and Aging. Adv Gerontol 2021;11:83-92. [DOI: 10.1134/s2079057021010458] [Reference Citation Analysis]
310 Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005;67:18-23. [PMID: 15885816 DOI: 10.1016/j.antiviral.2005.02.007] [Cited by in Crossref: 259] [Cited by in F6Publishing: 228] [Article Influence: 15.2] [Reference Citation Analysis]
311 Chan PK, To KF, Lo AW, Cheung JL, Chu I, Au FW, Tong JH, Tam JS, Sung JJ, Ng HK. Persistent infection of SARS coronavirus in colonic cells in vitro. J Med Virol 2004;74:1-7. [PMID: 15258961 DOI: 10.1002/jmv.20138] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
312 Chen J, Miao L, Li JM, Li YY, Zhu QY, Zhou CL, Fang HQ, Chen HP. Receptor-binding domain of SARS-Cov spike protein: Soluble expression in E.coli, purification and functional characterization. World J Gastroenterol 2005; 11(39): 6159-6164 [PMID: 16273643 DOI: 10.3748/wjg.v11.i39.6159] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
313 Lundin A, Dijkman R, Bergström T, Kann N, Adamiak B, Hannoun C, Kindler E, Jónsdóttir HR, Muth D, Kint J, Forlenza M, Müller MA, Drosten C, Thiel V, Trybala E. Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus. PLoS Pathog 2014;10:e1004166. [PMID: 24874215 DOI: 10.1371/journal.ppat.1004166] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 12.4] [Reference Citation Analysis]
314 Hong N, Du X, Nie Z, Li S. Diffusion-weighted MR study of femoral head avascular necrosis in severe acute respiratory syndrome patients. J Magn Reson Imaging 2005;22:661-4. [PMID: 16193472 DOI: 10.1002/jmri.20430] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
315 Saikatendu KS, Joseph JS, Subramanian V, Clayton T, Griffith M, Moy K, Velasquez J, Neuman BW, Buchmeier MJ, Stevens RC, Kuhn P. Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3. Structure 2005;13:1665-75. [PMID: 16271890 DOI: 10.1016/j.str.2005.07.022] [Cited by in Crossref: 144] [Cited by in F6Publishing: 133] [Article Influence: 10.3] [Reference Citation Analysis]
316 Leroy O. [Contribution of microbiological investigations to the diagnosis of lower respiratory tract infections]. Med Mal Infect 2006;36:570-98. [PMID: 17095176 DOI: 10.1016/j.medmal.2006.07.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
317 Zhang CH, Lu JH, Wang YF, Zheng HY, Xiong S, Zhang MY, Liu XJ, Li JX, Wan ZY, Yan XG, Qi SY, Cui Z, Zhang B. Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain. Vaccine 2005;23:3196-201. [PMID: 15837220 DOI: 10.1016/j.vaccine.2004.11.073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
318 McBryde ES, Gibson G, Pettitt AN, Zhang Y, Zhao B, McElwain DL. Bayesian modelling of an epidemic of severe acute respiratory syndrome. Bull Math Biol 2006;68:889-917. [PMID: 16802088 DOI: 10.1007/s11538-005-9005-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
319 Chen S, Hu T, Zhang J, Chen J, Chen K, Ding J, Jiang H, Shen X. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations. J Biol Chem 2008;283:554-64. [PMID: 17977841 DOI: 10.1074/jbc.M705240200] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
320 Frieman M, Basu D, Matthews K, Taylor J, Jones G, Pickles R, Baric R, Engel DA. Yeast based small molecule screen for inhibitors of SARS-CoV. PLoS One 2011;6:e28479. [PMID: 22164298 DOI: 10.1371/journal.pone.0028479] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
321 Kliger Y, Levanon EY. Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy. BMC Microbiol 2003;3:20. [PMID: 14499001 DOI: 10.1186/1471-2180-3-20] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
322 Chui L, Drebot M, Andonov A, Petrich A, Glushek M, Mahony J. Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods. Diagn Microbiol Infect Dis 2005;53:47-55. [PMID: 15994050 DOI: 10.1016/j.diagmicrobio.2005.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
323 Wang S, Sakhatskyy P, Chou TH, Lu S. Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV). J Immunol Methods 2005;301:21-30. [PMID: 15894326 DOI: 10.1016/j.jim.2005.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
324 Law HK, Cheung CY, Sia SF, Chan YO, Peiris JS, Lau YL. Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. BMC Immunol 2009;10:35. [PMID: 19505311 DOI: 10.1186/1471-2172-10-35] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
325 Lv Y, Ruan Z, Wang L, Ni B, Wu Y. Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV. BMC Immunol 2009;10:61. [PMID: 19958537 DOI: 10.1186/1471-2172-10-61] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
326 Chan HL, Tsui SK, Sung JJ. Coronavirus in severe acute respiratory syndrome (SARS). Trends Mol Med 2003;9:323-5. [PMID: 12928031 DOI: 10.1016/s1471-4914(03)00135-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
327 Tarnovitski N, Matthews LJ, Sui J, Gershoni JM, Marasco WA. Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides. J Mol Biol 2006;359:190-201. [PMID: 16630634 DOI: 10.1016/j.jmb.2006.03.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
328 Wan Y, Huang L, Zhang X, Shang J, Perlman S, Du L, Li F. Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein. Res Sq 2021:rs. [PMID: 34611654 DOI: 10.21203/rs.3.rs-736159/v2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
329 Gralinski LE, Ferris MT, Aylor DL, Whitmore AC, Green R, Frieman MB, Deming D, Menachery VD, Miller DR, Buus RJ, Bell TA, Churchill GA, Threadgill DW, Katze MG, McMillan L, Valdar W, Heise MT, Pardo-Manuel de Villena F, Baric RS. Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross. PLoS Genet 2015;11:e1005504. [PMID: 26452100 DOI: 10.1371/journal.pgen.1005504] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 13.6] [Reference Citation Analysis]
330 Adivitiya, Kaushik MS, Chakraborty S, Veleri S, Kateriya S. Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections. Biology (Basel) 2021;10:95. [PMID: 33572760 DOI: 10.3390/biology10020095] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
331 Hardenbrook NJ, Zhang P. A structural view of the SARS-CoV-2 virus and its assembly. Curr Opin Virol 2021;52:123-34. [PMID: 34915287 DOI: 10.1016/j.coviro.2021.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
332 Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, Law WL, Lee MP, Li PC. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003;58:686-9. [PMID: 12885985 DOI: 10.1136/thorax.58.8.686] [Cited by in Crossref: 216] [Cited by in F6Publishing: 203] [Article Influence: 11.4] [Reference Citation Analysis]
333 Kuiken T, Fouchier R, Rimmelzwaan G, Osterhaus A. Emerging viral infections in a rapidly changing world. Curr Opin Biotechnol 2003;14:641-6. [PMID: 14662395 DOI: 10.1016/j.copbio.2003.10.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
334 Wang Y, Liao B, Guo Y, Li F, Lei C, Zhang F, Cai W, Hong W, Zeng Y, Qiu S, Wang J, Li Y, Deng X, Li J, Xiao G, Guo F, Lai X, Liang Z, Wen X, Li P, Jiao Q, Xiang F, Wang Y, Ma C, Xie Z, Lin W, Wu Y, Tang X, Li L, Guan Y. Clinical Characteristics of Patients Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China. Open Forum Infect Dis. 2020;7:ofaa187. [PMID: 32577426 DOI: 10.1093/ofid/ofaa187] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
335 Farquharson C, Baguley K. Responding to the Severe Acute Respiratory Syndrome (SARS) Outbreak: Lessons Learned in a Toronto Emergency Department. J Emerg Nurs 2020;46:742-7. [PMID: 33162020 DOI: 10.1016/j.jen.2020.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
336 Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022. [PMID: 35354968 DOI: 10.1038/s41579-022-00713-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
337 Burkard C, Verheije MH, Haagmans BL, van Kuppeveld FJ, Rottier PJ, Bosch BJ, de Haan CA. ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells. J Virol 2015;89:4434-48. [PMID: 25653449 DOI: 10.1128/JVI.03274-14] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
338 Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004;10:S88-97. [PMID: 15577937 DOI: 10.1038/nm1143] [Cited by in Crossref: 636] [Cited by in F6Publishing: 564] [Article Influence: 37.4] [Reference Citation Analysis]
339 Xia J, Tang W, Wang J, Lai D, Xu Q, Huang R, Hu Y, Gong X, Fan J, Shu Q, Xu J. SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice via NF-ĸB Activation. Front Immunol 2021;12:791753. [PMID: 34950152 DOI: 10.3389/fimmu.2021.791753] [Reference Citation Analysis]
340 Oxford J, Balasingam S, Lambkin R. A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community. J Antimicrob Chemother 2004;53:133-6. [PMID: 14688047 DOI: 10.1093/jac/dkh037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
341 Lipkin WI. Pathogen discovery. PLoS Pathog 2008;4:e1000002. [PMID: 18437241 DOI: 10.1371/journal.ppat.1000002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
342 Shih MC, Peck K, Chan WL, Chu YP, Chen JC, Tsai CH, Chang JG. SARS-CoV infection was from at least two origins in the Taiwan area. Intervirology 2005;48:124-32. [PMID: 15812185 DOI: 10.1159/000081739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
343 Poon LLM, Chan KH, Nicholls JM, Zheng BJ, Yuen KY, Guan Y, Peiris JSM. Characterization of a novel coronavirus responsible for severe acute respiratory syndrome. Int Congr Ser 2004;1263:805-8. [PMID: 32288144 DOI: 10.1016/j.ics.2004.02.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
344 Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, Yan KW, Chan KH, Tsang NC, Guan Y, Yuen KY, Peiris JS. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773-1778. [PMID: 12781536 DOI: 10.1016/s0140-6736(03)13413-7] [Cited by in Crossref: 687] [Cited by in F6Publishing: 522] [Article Influence: 36.2] [Reference Citation Analysis]
345 Tsui WMS. Coronavirus is the cause of the severe acute respiratory syndrome (SARS) outbreak in Hong Kong and worldwide: . Advances in Anatomic Pathology 2003;10:236. [DOI: 10.1097/00125480-200307000-00008] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
346 Moës E, Vijgen L, Keyaerts E, Zlateva K, Li S, Maes P, Pyrc K, Berkhout B, van der Hoek L, Van Ranst M. A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis 2005;5:6. [PMID: 15686594 DOI: 10.1186/1471-2334-5-6] [Cited by in Crossref: 109] [Cited by in F6Publishing: 108] [Article Influence: 6.4] [Reference Citation Analysis]
347 Hon KL, Leung CW, Cheng WT, Chan PK, Chu WC, Kwan YW, Li AM, Fong NC, Ng PC, Chiu MC, Li CK, Tam JS, Fok TF. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003;361:1701-3. [PMID: 12767737 DOI: 10.1016/s0140-6736(03)13364-8] [Cited by in Crossref: 248] [Cited by in F6Publishing: 163] [Article Influence: 13.1] [Reference Citation Analysis]
348 Hetrick B, Yu D, Olanrewaju AA, Chilin LD, He S, Dabbagh D, Alluhaibi G, Ma YC, Hofmann LA, Hakami RM, Wu Y. A traditional medicine, respiratory detox shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the influenza A virus in vitro. Cell Biosci 2021;11:100. [PMID: 34051873 DOI: 10.1186/s13578-021-00609-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
349 Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis. 2003;3:722-727. [PMID: 14592603 DOI: 10.1016/s1473-3099(03)00806-5] [Cited by in Crossref: 702] [Cited by in F6Publishing: 459] [Article Influence: 36.9] [Reference Citation Analysis]
350 De Clercq E. Potential antivirals and antiviral strategies against SARS coronavirus infections. Expert Rev Anti Infect Ther 2006;4:291-302. [PMID: 16597209 DOI: 10.1586/14787210.4.2.291] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 5.9] [Reference Citation Analysis]
351 Navas-Martín SR, Weiss S. Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. J Neurovirol 2004;10:75-85. [PMID: 15204926 DOI: 10.1080/13550280490280292] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
352 Konno S, Thanigaimalai P, Yamamoto T, Nakada K, Kakiuchi R, Takayama K, Yamazaki Y, Yakushiji F, Akaji K, Kiso Y, Kawasaki Y, Chen SE, Freire E, Hayashi Y. Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety. Bioorg Med Chem 2013;21:412-24. [PMID: 23245752 DOI: 10.1016/j.bmc.2012.11.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
353 Zhou J, Wang W, Zhong Q, Hou W, Yang Z, Xiao SY, Zhu R, Tang Z, Wang Y, Xian Q, Tang H, Wen L. Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys. Vaccine 2005;23:3202-9. [PMID: 15837221 DOI: 10.1016/j.vaccine.2004.11.075] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
354 Wen X, Huang Q, Tao H, Zou W, Gao M, Guo H, Yao X, Cui D, Wang X. Clinical characteristics and viral etiologies of outpatients with acute respiratory infections in Huzhou of China: a retrospective study. BMC Infect Dis 2019;19:32. [PMID: 30621623 DOI: 10.1186/s12879-018-3668-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
355 Arslan M, Xu B, Gamal El-Din M. Transmission of SARS-CoV-2 via fecal-oral and aerosols-borne routes: Environmental dynamics and implications for wastewater management in underprivileged societies. Sci Total Environ 2020;743:140709. [PMID: 32652357 DOI: 10.1016/j.scitotenv.2020.140709] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 29.0] [Reference Citation Analysis]
356 Karlberg J, Chong DS, Lai WY. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol 2004;159:229-31. [PMID: 14742282 DOI: 10.1093/aje/kwh056] [Cited by in Crossref: 250] [Cited by in F6Publishing: 220] [Article Influence: 13.9] [Reference Citation Analysis]
357 Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020;79:104212. [PMID: 32004758 DOI: 10.1016/j.meegid.2020.104212] [Cited by in Crossref: 302] [Cited by in F6Publishing: 258] [Article Influence: 151.0] [Reference Citation Analysis]
358 Kalathiya U, Padariya M, Mayordomo M, Lisowska M, Nicholson J, Singh A, Baginski M, Fahraeus R, Carragher N, Ball K, Haas J, Daniels A, Hupp TR, Alfaro JA. Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site. J Clin Med 2020;9:E1473. [PMID: 32422996 DOI: 10.3390/jcm9051473] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
359 Hsu MF, Kuo CJ, Chang KT, Chang HC, Chou CC, Ko TP, Shr HL, Chang GG, Wang AH, Liang PH. Mechanism of the maturation process of SARS-CoV 3CL protease. J Biol Chem 2005;280:31257-66. [PMID: 15788388 DOI: 10.1074/jbc.M502577200] [Cited by in Crossref: 131] [Cited by in F6Publishing: 94] [Article Influence: 7.7] [Reference Citation Analysis]
360 Mo Y, Fisher D. A review of treatment modalities for Middle East Respiratory Syndrome. J Antimicrob Chemother. 2016;71:3340-3350. [PMID: 27585965 DOI: 10.1093/jac/dkw338] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 11.2] [Reference Citation Analysis]
361 Schwarz GM, Yang K, Chou C, Chiu Y. A classification of structural inertia: Variations in structural response. Asia Pac J Manag 2020;37:33-63. [DOI: 10.1007/s10490-018-9588-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
362 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Reference Citation Analysis]
363 DeDiego ML, Alvarez E, Almazán F, Rejas MT, Lamirande E, Roberts A, Shieh WJ, Zaki SR, Subbarao K, Enjuanes L. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol 2007;81:1701-13. [PMID: 17108030 DOI: 10.1128/JVI.01467-06] [Cited by in Crossref: 221] [Cited by in F6Publishing: 172] [Article Influence: 13.8] [Reference Citation Analysis]
364 Bogaards JA, Putter H, Jan Weverling G, Ter Meulen J, Goudsmit J. The potential of targeted antibody prophylaxis in SARS outbreak control: a mathematic analysis. Travel Med Infect Dis 2007;5:70-8. [PMID: 17298911 DOI: 10.1016/j.tmaid.2006.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
365 Lung T, Kazatchkine MD, Risch L, Risch M, Nydegger UE. A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19. Transfus Apher Sci 2020;59:102936. [PMID: 32919880 DOI: 10.1016/j.transci.2020.102936] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
366 De Groot AS. How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past. Vaccine 2003;21:4095-104. [PMID: 14505885 DOI: 10.1016/s0264-410x(03)00489-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
367 Muradrasoli S, Mohamed N, Hornyák A, Fohlman J, Olsen B, Belák S, Blomberg J. Broadly targeted multiprobe QPCR for detection of coronaviruses: Coronavirus is common among mallard ducks (Anas platyrhynchos). J Virol Methods 2009;159:277-87. [PMID: 19406168 DOI: 10.1016/j.jviromet.2009.04.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
368 Hui DS, Chan MC, Wu AK, Ng PC. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J 2004;80:373-81. [PMID: 15254300 DOI: 10.1136/pgmj.2004.020263] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
369 Rajpal VR, Sharma S, Sehgal D, Singh A, Kumar A, Vaishnavi S, Tiwari M, Bhalla H, Goel S, Raina SN. A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program. Future Virol 2022. [PMID: 35747328 DOI: 10.2217/fvl-2021-0277] [Reference Citation Analysis]
370 Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z, Ye D, Liu J, Wan J. Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed Pharmacother 2020;127:110230. [PMID: 32428835 DOI: 10.1016/j.biopha.2020.110230] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
371 Day CW, Baric R, Cai SX, Frieman M, Kumaki Y, Morrey JD, Smee DF, Barnard DL. A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo. Virology 2009;395:210-22. [PMID: 19853271 DOI: 10.1016/j.virol.2009.09.023] [Cited by in Crossref: 94] [Cited by in F6Publishing: 97] [Article Influence: 7.2] [Reference Citation Analysis]
372 Lacroix A, Vidal N, Keita AK, Thaurignac G, Esteban A, De Nys H, Diallo R, Toure A, Goumou S, Soumah AK, Povogui M, Koivogui J, Monemou JL, Raulino R, Nkuba A, Foulongne V, Delaporte E, Ayouba A, Peeters M. Wide Diversity of Coronaviruses in Frugivorous and Insectivorous Bat Species: A Pilot Study in Guinea, West Africa. Viruses 2020;12:E855. [PMID: 32764506 DOI: 10.3390/v12080855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
373 Islam MM, Mahmud S, Muhammad LJ, Islam MR, Nooruddin S, Ayon SI. Wearable Technology to Assist the Patients Infected with Novel Coronavirus (COVID-19). SN Comput Sci 2020;1:320. [PMID: 33063058 DOI: 10.1007/s42979-020-00335-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
374 Cheung BMY, Yau HKC. Clinical Therapeutics in Hong Kong. Clin Ther 2019;41:592-7. [PMID: 30709611 DOI: 10.1016/j.clinthera.2019.01.002] [Reference Citation Analysis]
375 Li T, Zhang Y, Fu L, Yu C, Li X, Li Y, Zhang X, Rong Z, Wang Y, Ning H. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication. Gene Ther. 2005;12:751-761. [PMID: 15772689 DOI: 10.1038/sj.gt.3302479] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
376 Rayati Damavandi A, Dowran R, Al Sharif S, Kashanchi F, Jafari R. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy. Med Microbiol Immunol 2022. [PMID: 35235048 DOI: 10.1007/s00430-022-00729-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
377 . EMERGING RESPIRATORY DISEASE - CORONAVIRUSES. Dis Mon 2017;63:256-62. [PMID: 29737283 DOI: 10.1016/j.disamonth.2017.03.019] [Reference Citation Analysis]
378 Smales FC, Samaranyake LP. Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 2: Control of the disease, then elimination. Br Dent J 2003;195:679-81. [PMID: 14718953 DOI: 10.1038/sj.bdj.4810819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
379 Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 Lineage. J Mol Biol. 2003;331:991-1004. [PMID: 12927536 DOI: 10.1016/s0022-2836(03)00865-9] [Cited by in Crossref: 829] [Cited by in F6Publishing: 671] [Article Influence: 43.6] [Reference Citation Analysis]
380 Lau SK, Woo PC, Yip CC, Fan RY, Huang Y, Wang M, Guo R, Lam CS, Tsang AK, Lai KK, Chan KH, Che XY, Zheng BJ, Yuen KY. Isolation and characterization of a novel Betacoronavirus subgroup A coronavirus, rabbit coronavirus HKU14, from domestic rabbits. J Virol 2012;86:5481-96. [PMID: 22398294 DOI: 10.1128/JVI.06927-11] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
381 Wilson L, McKinlay C, Gage P, Ewart G. SARS coronavirus E protein forms cation-selective ion channels. Virology 2004;330:322-31. [PMID: 15527857 DOI: 10.1016/j.virol.2004.09.033] [Cited by in Crossref: 175] [Cited by in F6Publishing: 156] [Article Influence: 10.3] [Reference Citation Analysis]
382 Chang FY, Chen HC, Chen PJ, Ho MS, Hsieh SL, Lin JC, Liu FT, Sytwu HK. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). J Biomed Sci 2020;27:72. [PMID: 32498686 DOI: 10.1186/s12929-020-00663-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
383 Feng D, de Vlas SJ, Fang LQ, Han XN, Zhao WJ, Sheng S, Yang H, Jia ZW, Richardus JH, Cao WC. The SARS epidemic in mainland China: bringing together all epidemiological data. Trop Med Int Health 2009;14 Suppl 1:4-13. [PMID: 19508441 DOI: 10.1111/j.1365-3156.2008.02145.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
384 Gerna G, Campanini G, Rovida F, Percivalle E, Sarasini A, Marchi A, Baldanti F. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol 2006;78:938-49. [PMID: 16721849 DOI: 10.1002/jmv.20645] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 6.9] [Reference Citation Analysis]
385 Kim HJ. Novel respiratory infectious diseases in Korea. Yeungnam Univ J Med 2020;37:286-95. [PMID: 33045803 DOI: 10.12701/yujm.2020.00633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Tsai MH, Lin TY, Chiu CH, Lin PY, Huang YC, Tsao KC, Huang CG, Hsu KH, Lin MC, Hwang KP, Yang KD. Seroprevalence of SARS Coronavirus Among Residents Near a Hospital with a Nosocomial Outbreak. J Formos Med Assoc 2008;107:885-91. [PMID: 18971158 DOI: 10.1016/S0929-6646(08)60205-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
387 He J, Tao H, Yan Y, Huang SY, Xiao Y. Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2. Viruses 2020;12:E428. [PMID: 32290077 DOI: 10.3390/v12040428] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 34.5] [Reference Citation Analysis]
388 Al-kuraishy HM, Al-gareeb AI. From SARS-CoV to nCoV-2019: Ruction and Argument. Arch Clin Infect Dis 2020;15. [DOI: 10.5812/archcid.102624] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
389 Fukushi M, Yoshinaka Y, Matsuoka Y, Hatakeyama S, Ishizaka Y, Kirikae T, Sasazuki T, Miyoshi-Akiyama T. Monitoring of S protein maturation in the endoplasmic reticulum by calnexin is important for the infectivity of severe acute respiratory syndrome coronavirus. J Virol 2012;86:11745-53. [PMID: 22915798 DOI: 10.1128/JVI.01250-12] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
390 Chen Z, Zhang L, Qin C, Ba L, Yi CE, Zhang F, Wei Q, He T, Yu W, Yu J, Gao H, Tu X, Gettie A, Farzan M, Yuen KY, Ho DD. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol 2005;79:2678-88. [PMID: 15708987 DOI: 10.1128/JVI.79.5.2678-2688.2005] [Cited by in Crossref: 147] [Cited by in F6Publishing: 120] [Article Influence: 8.6] [Reference Citation Analysis]
391 Vijayachandran LS, Viola C, Garzoni F, Trowitzsch S, Bieniossek C, Chaillet M, Schaffitzel C, Busso D, Romier C, Poterszman A, Richmond TJ, Berger I. Robots, pipelines, polyproteins: enabling multiprotein expression in prokaryotic and eukaryotic cells. J Struct Biol 2011;175:198-208. [PMID: 21419851 DOI: 10.1016/j.jsb.2011.03.007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 6.7] [Reference Citation Analysis]
392 Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci Total Environ 2020;730:138996. [PMID: 32371230 DOI: 10.1016/j.scitotenv.2020.138996] [Cited by in Crossref: 124] [Cited by in F6Publishing: 93] [Article Influence: 62.0] [Reference Citation Analysis]
393 Zuwała K, Golda A, Kabala W, Burmistrz M, Zdzalik M, Nowak P, Kedracka-Krok S, Zarebski M, Dobrucki J, Florek D, Zeglen S, Wojarski J, Potempa J, Dubin G, Pyrc K. The nucleocapsid protein of human coronavirus NL63. PLoS One 2015;10:e0117833. [PMID: 25700263 DOI: 10.1371/journal.pone.0117833] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
394 Sakudo A, Suganuma Y, Kobayashi T, Onodera T, Ikuta K. Near-infrared spectroscopy: promising diagnostic tool for viral infections. Biochem Biophys Res Commun 2006;341:279-84. [PMID: 16414011 DOI: 10.1016/j.bbrc.2005.12.153] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
395 Zheng Z, Yao Z, Wu K, Zheng J. The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test. J Clin Virol 2020;128:104396. [PMID: 32438256 DOI: 10.1016/j.jcv.2020.104396] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
396 Kao RY, Tsui WH, Lee TS, Tanner JA, Watt RM, Huang JD, Hu L, Chen G, Chen Z, Zhang L, He T, Chan KH, Tse H, To AP, Ng LW, Wong BC, Tsoi HW, Yang D, Ho DD, Yuen KY. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chem Biol 2004;11:1293-9. [PMID: 15380189 DOI: 10.1016/j.chembiol.2004.07.013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 6.1] [Reference Citation Analysis]
397 Kang X, Xu Y, Wu X, Liang Y, Wang C, Guo J, Wang Y, Chen M, Wu D, Wang Y. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem. 2005;51:56-64. [PMID: 15550479 DOI: 10.1373/clinchem.2004.032458] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
398 van den Brink EN, Ter Meulen J, Cox F, Jongeneelen MA, Thijsse A, Throsby M, Marissen WE, Rood PM, Bakker AB, Gelderblom HR, Martina BE, Osterhaus AD, Preiser W, Doerr HW, de Kruif J, Goudsmit J. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J Virol 2005;79:1635-44. [PMID: 15650189 DOI: 10.1128/JVI.79.3.1635-1644.2005] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 6.1] [Reference Citation Analysis]
399 Zhang Y, Hung T, Song J, He J. Electron microscopy: essentials for viral structure, morphogenesis and rapid diagnosis. Sci China Life Sci 2013;56:421-30. [PMID: 23633074 DOI: 10.1007/s11427-013-4476-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
400 El-Shehawi AM, Alotaibi SS, Elseehy MM. Genomic Study of COVID-19 Corona Virus Excludes Its Origin from Recombination or Characterized Biological Sources and Suggests a Role for HERVS in Its Wide Range Symptoms. Cytol Genet 2020;54:588-604. [PMID: 33487779 DOI: 10.3103/S0095452720060031] [Reference Citation Analysis]
401 Yoo HM, Kim IH, Kim S. Nucleic Acid Testing of SARS-CoV-2. Int J Mol Sci 2021;22:6150. [PMID: 34200331 DOI: 10.3390/ijms22116150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
402 López-Cortés GI, Palacios-Pérez M, Zamudio GS, Veledíaz HF, Ortega E, José MV. Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2. Sci Rep 2021;11:18847. [PMID: 34552110 DOI: 10.1038/s41598-021-96950-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
403 Lau SK, Poon RW, Wong BH, Wang M, Huang Y, Xu H, Guo R, Li KS, Gao K, Chan KH, Zheng BJ, Woo PC, Yuen KY. Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup. J Virol 2010;84:11385-94. [PMID: 20702646 DOI: 10.1128/JVI.01121-10] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
404 Vicenzi E, Canducci F, Pinna D, Mancini N, Carletti S, Lazzarin A, Bordignon C, Poli G, Clementi M. Coronaviridae and SARS-associated coronavirus strain HSR1. Emerg Infect Dis 2004;10:413-8. [PMID: 15109406 DOI: 10.3201/eid1003.030683] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
405 Foulongne V, Lechiche C, Reynes J, Segondy M. [Human metapneumovirus pneumonia in an adult patient hospitalized for suspected severe acute respiratory syndrome (SARS)]. Presse Med 2004;33:1006-7. [PMID: 15523245 DOI: 10.1016/s0755-4982(04)98824-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
406 Bhaskar G, Lodha R, Kabra SK. Severe acute respiratory syndrome (SARS). Indian J Pediatr 2003;70:401-5. [PMID: 12841401 DOI: 10.1007/BF02723614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
407 Bartlam M, Xu Y, Rao Z. Structural proteomics of the SARS coronavirus: a model response to emerging infectious diseases. J Struct Funct Genomics 2007;8:85-97. [PMID: 17680348 DOI: 10.1007/s10969-007-9024-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
408 Ma Y, Chan CY, He ML. RNA interference and antiviral therapy. World J Gastroenterol 2007; 13(39): 5169-5179 [PMID: 17876887 DOI: 10.3748/wjg.v13.i39.5169] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
409 Chatterjee A, Johnson MA, Serrano P, Pedrini B, Wüthrich K. NMR assignment of the domain 513-651 from the SARS-CoV nonstructural protein nsp3. Biomol NMR Assign 2007;1:191-4. [PMID: 19636862 DOI: 10.1007/s12104-007-9052-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
410 Heymann DL, Mackenzie JS, Peiris M. SARS legacy: outbreak reporting is expected and respected. Lancet 2013;381:779-81. [PMID: 23668493 DOI: 10.1016/S0140-6736(13)60185-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
411 Chen S, Zhang J, Hu T, Chen K, Jiang H, Shen X. Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis. J Biochem 2008;143:525-36. [PMID: 18182387 DOI: 10.1093/jb/mvm246] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
412 Zhang H, Wang G, Li J, Nie Y, Shi X, Lian G, Wang W, Yin X, Zhao Y, Qu X, Ding M, Deng H. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. J Virol 2004;78:6938-45. [PMID: 15194770 DOI: 10.1128/JVI.78.13.6938-6945.2004] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
413 Lu X, Chen Y, Bai B, Hu H, Tao L, Yang J, Chen J, Chen Z, Hu Z, Wang H. Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice. Immunology 2007;122:496-502. [PMID: 17680799 DOI: 10.1111/j.1365-2567.2007.02676.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
414 Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L, Song S, Ma Z, Mo P, Zhang Y. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis 2020;221:1762-9. [PMID: 32227123 DOI: 10.1093/infdis/jiaa150] [Cited by in Crossref: 442] [Cited by in F6Publishing: 424] [Article Influence: 221.0] [Reference Citation Analysis]
415 Lee TW, Cherney MM, Liu J, James KE, Powers JC, Eltis LD, James MN. Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptide epoxide to SARS coronavirus main peptidase. J Mol Biol 2007;366:916-32. [PMID: 17196984 DOI: 10.1016/j.jmb.2006.11.078] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
416 Cheung TM, Yam LY, So LK, Lau AC, Poon E, Kong BM, Yung RW. Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome. Chest 2004;126:845-50. [PMID: 15364765 DOI: 10.1378/chest.126.3.845] [Cited by in Crossref: 118] [Cited by in F6Publishing: 75] [Article Influence: 6.6] [Reference Citation Analysis]
417 Balzarini J, Keyaerts E, Vijgen L, Egberink H, De Clercq E, Van Ranst M, Printsevskaya SS, Olsufyeva EN, Solovieva SE, Preobrazhenskaya MN. Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics. Antiviral Res 2006;72:20-33. [PMID: 16675038 DOI: 10.1016/j.antiviral.2006.03.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
418 Kumar D, Chauhan G, Kalra S, Kumar B, Gill MS. A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules. Bioorg Chem 2020;104:104326. [PMID: 33142431 DOI: 10.1016/j.bioorg.2020.104326] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
419 Spiegel M, Pichlmair A, Martínez-Sobrido L, Cros J, García-Sastre A, Haller O, Weber F. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol. 2005;79:2079-2086. [PMID: 15681410 DOI: 10.1128/JVI.79.4.2079-2086.2005] [Cited by in Crossref: 211] [Cited by in F6Publishing: 163] [Article Influence: 12.4] [Reference Citation Analysis]
420 Martinez DR, Schaefer A, Gobeil S, Li D, De la Cruz G, Parks R, Lu X, Barr M, Manne K, Mansouri K, Edwards RJ, Yount B, Anasti K, Montgomery SA, Shen S, Zhou T, Kwong PD, Graham BS, Mascola JR, Montefiori DC, Alam M, Sempowski GD, Wiehe K, Saunders KO, Acharya P, Haynes BF, Baric RS. A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice. bioRxiv 2021:2021. [PMID: 33948590 DOI: 10.1101/2021.04.27.441655] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 11.0] [Reference Citation Analysis]
421 Erles K, Brownlie J. Canine respiratory coronavirus: an emerging pathogen in the canine infectious respiratory disease complex. Vet Clin North Am Small Anim Pract 2008;38:815-25, viii. [PMID: 18501280 DOI: 10.1016/j.cvsm.2008.02.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
422 Canard B, Joseph JS, Kuhn P. International research networks in viral structural proteomics: again, lessons from SARS. Antiviral Res 2008;78:47-50. [PMID: 18054092 DOI: 10.1016/j.antiviral.2007.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
423 Lau SK, Woo PC, Wong BH, Tsoi HW, Woo GK, Poon RW, Chan KH, Wei WI, Peiris JS, Yuen KY. Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay. J Clin Microbiol 2004;42:2884-9. [PMID: 15243033 DOI: 10.1128/JCM.42.7.2884-2889.2004] [Cited by in Crossref: 84] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
424 Wang H, Rong F, Ke F, Bai Y. Control dynamics of severe acute respiratory syndrome transmission. Chin Sci Bull 2003;48:2684-7. [PMID: 32214709 DOI: 10.1007/BF02901756] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
425 Hu H, Huang X, Tao L, Huang Y, Cui BA, Wang H. Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model. Vaccine 2009;27:1758-63. [PMID: 19186202 DOI: 10.1016/j.vaccine.2009.01.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
426 Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol. 2020;73:1231-1240. [PMID: 32553666 DOI: 10.1016/j.jhep.2020.06.006] [Cited by in Crossref: 122] [Cited by in F6Publishing: 115] [Article Influence: 61.0] [Reference Citation Analysis]
427 Wong GW, Li AM, Ng PC, Fok TF. Severe acute respiratory syndrome in children. Pediatr Pulmonol 2003;36:261-6. [PMID: 12950037 DOI: 10.1002/ppul.10367] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
428 Chen Z, Lv Y, Xu H, Deng L. Herbal Medicine, Gut Microbiota, and COVID-19. Front Pharmacol 2021;12:646560. [PMID: 34305582 DOI: 10.3389/fphar.2021.646560] [Reference Citation Analysis]
429 Cappy P, Candotti D, Sauvage V, Lucas Q, Boizeau L, Gomez J, Enouf V, Chabli L, Pillonel J, Tiberghien P, Morel P, Laperche S. No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation. Blood 2020;136:1888-91. [PMID: 32871595 DOI: 10.1182/blood.2020008230] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
430 Lu H, Zhao Y, Zhang J, Wang Y, Li W, Zhu X, Sun S, Xu J, Ling L, Cai L, Bu D, Chen R. Date of origin of the SARS coronavirus strains. BMC Infect Dis 2004;4:3. [PMID: 15028113 DOI: 10.1186/1471-2334-4-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
431 Wu J, Xu F, Zhou W, Feikin DR, Lin CY, He X, Zhu Z, Liang W, Chin DP, Schuchat A. Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis 2004;10:210-6. [PMID: 15030685 DOI: 10.3201/eid1002.030730] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 5.4] [Reference Citation Analysis]
432 Swayne DE, Suarez DL, Spackman E, Tumpey TM, Beck JR, Erdman D, Rollin PE, Ksiazek TG. Domestic poultry and SARS coronavirus, southern China. Emerg Infect Dis 2004;10:914-6. [PMID: 15200830 DOI: 10.3201/eid1005.030827] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
433 Goebel SJ, Taylor J, Barr BC, Kiehn TE, Castro-Malaspina HR, Hedvat CV, Rush-Wilson KA, Kelly CD, Davis SW, Samsonoff WA, Hurst KR, Behr MJ, Masters PS. Isolation of avian paramyxovirus 1 from a patient with a lethal case of pneumonia. J Virol 2007;81:12709-14. [PMID: 17855523 DOI: 10.1128/JVI.01406-07] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
434 Liang Y, Wan Y, Qiu LW, Zhou J, Ni B, Guo B, Zou Q, Zou L, Zhou W, Jia Z, Che XY, Wu Y. Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: insight into the humoral immunity of SARS. Clin Chem 2005;51:1382-96. [PMID: 15976093 DOI: 10.1373/clinchem.2005.051045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
435 Wang F, Chen C, Wang Z, Han X, Shi P, Zhou K, Liu X, Xiao Y, Cai Y, Huang J, Zhang L, Yang H. The Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals. Viruses 2022;14:486. [DOI: 10.3390/v14030486] [Reference Citation Analysis]
436 Yuan S, Yin X, Meng X, Chan JF, Ye ZW, Riva L, Pache L, Chan CC, Lai PM, Chan CC, Poon VK, Lee AC, Matsunaga N, Pu Y, Yuen CK, Cao J, Liang R, Tang K, Sheng L, Du Y, Xu W, Lau CY, Sit KY, Au WK, Wang R, Zhang YY, Tang YD, Clausen TM, Pihl J, Oh J, Sze KH, Zhang AJ, Chu H, Kok KH, Wang D, Cai XH, Esko JD, Hung IF, Li RA, Chen H, Sun H, Jin DY, Sun R, Chanda SK, Yuen KY. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2. Nature 2021;593:418-23. [PMID: 33727703 DOI: 10.1038/s41586-021-03431-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
437 Sun L, Li P, Ju X, Rao J, Huang W, Ren L, Zhang S, Xiong T, Xu K, Zhou X, Gong M, Miska E, Ding Q, Wang J, Zhang QC. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs. Cell 2021;184:1865-1883.e20. [PMID: 33636127 DOI: 10.1016/j.cell.2021.02.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 18.0] [Reference Citation Analysis]
438 Sørensen MD, Sørensen B, Gonzalez-Dosal R, Melchjorsen CJ, Weibel J, Wang J, Jun CW, Huanming Y, Kristensen P. Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals. Ann N Y Acad Sci. 2006;1067:500-505. [PMID: 16804033 DOI: 10.1196/annals.1354.072] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
439 Ge XY, Wang N, Zhang W, Hu B, Li B, Zhang YZ, Zhou JH, Luo CM, Yang XL, Wu LJ, Wang B, Zhang Y, Li ZX, Shi ZL. Coexistence of multiple coronaviruses in several bat colonies in an abandoned mineshaft. Virol Sin 2016;31:31-40. [PMID: 26920708 DOI: 10.1007/s12250-016-3713-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]
440 Bhardwaj VK, Singh R, Sharma J, Rajendran V, Purohit R, Kumar S. Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2. Front Med (Lausanne) 2021;8:684020. [PMID: 34136511 DOI: 10.3389/fmed.2021.684020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
441 Haynes LM, Miao C, Harcourt JL, Montgomery JM, Le MQ, Dryga SA, Kamrud KI, Rivers B, Babcock GJ, Oliver JB, Comer JA, Reynolds M, Uyeki TM, Bausch D, Ksiazek T, Thomas W, Alterson H, Smith J, Ambrosino DM, Anderson LJ. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins. Clin Vaccine Immunol 2007;14:331-3. [PMID: 17229882 DOI: 10.1128/CVI.00351-06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
442 Hui DS, Chan PK. Severe acute respiratory syndrome and coronavirus. Infect Dis Clin North Am 2010;24:619-38. [PMID: 20674795 DOI: 10.1016/j.idc.2010.04.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
443 Zhao GP. SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era. Philos Trans R Soc Lond B Biol Sci 2007;362:1063-81. [PMID: 17327210 DOI: 10.1098/rstb.2007.2034] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
444 Lin Q, Lu C, Hong Y, Li R, Chen J, Chen W, Chen J. Animal models for studying coronavirus infections and developing antiviral agents and vaccines. Antiviral Research 2022. [DOI: 10.1016/j.antiviral.2022.105345] [Reference Citation Analysis]
445 Nagata N, Iwata N, Hasegawa H, Sato Y, Morikawa S, Saijo M, Itamura S, Saito T, Ami Y, Odagiri T, Tashiro M, Sata T. Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes. Int J Exp Pathol 2007;88:403-14. [PMID: 18039277 DOI: 10.1111/j.1365-2613.2007.00567.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
446 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(7): 881-887 [DOI: 10.11569/wcjd.v11.i7.881] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
447 Zhao J, Huang Q, Wang W, Zhang Y, Lv P, Gao XM. Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 2007;81:6079-88. [PMID: 17392374 DOI: 10.1128/JVI.02568-06] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
448 Wang WK, Chen SY, Liu IJ, Chen YC, Chen HL, Yang CF, Chen PJ, Yeh SH, Kao CL, Huang LM, Hsueh PR, Wang JT, Sheng WH, Fang CT, Hung CC, Hsieh SM, Su CP, Chiang WC, Yang JY, Lin JH, Hsieh SC, Hu HP, Chiang YP, Wang JT, Yang PC, Chang SC; SARS Research Group of the National Taiwan University/National Taiwan University Hospital. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis 2004;10:1213-9. [PMID: 15324540 DOI: 10.3201/eid1007.031113] [Cited by in Crossref: 132] [Cited by in F6Publishing: 116] [Article Influence: 7.3] [Reference Citation Analysis]
449 Abdullah AS, Thomas GN, McGhee SM, Morisky DE. Impact of severe acute respiratory syndrome (SARS) on travel and population mobility: implications for travel medicine practitioners. J Travel Med 2004;11:107-11. [PMID: 15109476 DOI: 10.2310/7060.2004.17067] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
450 Krokhin O, Li Y, Andonov A, Feldmann H, Flick R, Jones S, Stroeher U, Bastien N, Dasuri KV, Cheng K, Simonsen JN, Perreault H, Wilkins J, Ens W, Plummer F, Standing KG. Mass spectrometric characterization of proteins from the SARS virus: a preliminary report. Mol Cell Proteomics 2003;2:346-56. [PMID: 12775768 DOI: 10.1074/mcp.M300048-MCP200] [Cited by in Crossref: 114] [Cited by in F6Publishing: 88] [Article Influence: 6.0] [Reference Citation Analysis]
451 Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Characteristics of 1 062 patients with SARS in early stage in Beijing. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1149-1154 [DOI: 10.11569/wcjd.v12.i5.1149] [Reference Citation Analysis]
452 Bossi P, Guihot A, Ansart S, Bricaire F. [Severe acute respiratory syndrome: update]. Rev Med Interne 2003;24:672-80. [PMID: 14550520 DOI: 10.1016/s0248-8663(03)00262-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
453 Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY. Zoonotic origins of human coronaviruses. Int J Biol Sci 2020;16:1686-97. [PMID: 32226286 DOI: 10.7150/ijbs.45472] [Cited by in Crossref: 293] [Cited by in F6Publishing: 248] [Article Influence: 146.5] [Reference Citation Analysis]
454 Zeng F, Hon CC, Yip CW, Law KM, Yeung YS, Chan KH, Malik Peiris JS, Leung FC. Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit. FEBS Lett 2006;580:5612-20. [PMID: 16989815 DOI: 10.1016/j.febslet.2006.08.085] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
455 Nielsen SCA, Yang F, Jackson KJL, Hoh RA, Röltgen K, Stevens B, Lee JY, Rustagi A, Rogers AJ, Powell AE, Najeeb J, Otrelo-Cardoso AR, Yost KE, Daniel B, Chang HY, Satpathy AT, Jardetzky TS, Kim PS, Wang TT, Pinsky BA, Blish CA, Boyd SD. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32676593 DOI: 10.1101/2020.07.08.194456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
456 Borgio JF, Alsuwat HS, Al Otaibi WM, Ibrahim AM, Almandil NB, Al Asoom LI, Salahuddin M, Kamaraj B, AbdulAzeez S. State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2. Arch Med Sci 2020;16:508-18. [PMID: 32399096 DOI: 10.5114/aoms.2020.94567] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
457 Shah N, Davariya V, Gupta SK, Gajjar P, Parmar J, D'Cruz L. Review: An insight into coronaviruses: Challenges, security and scope. Rev Med Virol 2020;30:1-8. [PMID: 32754974 DOI: 10.1002/rmv.2138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
458 Hu W, Bai B, Hu Z, Chen Z, An X, Tang L, Yang J, Wang H, Wang H. Development and evaluation of a multitarget real-time Taqman reverse transcription-PCR assay for detection of the severe acute respiratory syndrome-associated coronavirus and surveillance for an apparently related coronavirus found in masked palm civets. J Clin Microbiol 2005;43:2041-6. [PMID: 15872219 DOI: 10.1128/JCM.43.5.2041-2046.2005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
459 Hoque MN, Faisal GM, Chowdhury FR, Haque A, Islam T. The urgency of wider adoption of one health approach for the prevention of a future pandemic. Int J One Health. [DOI: 10.14202/ijoh.2022.20-33] [Reference Citation Analysis]
460 Tripet B, Howard MW, Jobling M, Holmes RK, Holmes KV, Hodges RS. Structural characterization of the SARS-coronavirus spike S fusion protein core. J Biol Chem 2004;279:20836-49. [PMID: 14996844 DOI: 10.1074/jbc.M400759200] [Cited by in Crossref: 148] [Cited by in F6Publishing: 116] [Article Influence: 8.2] [Reference Citation Analysis]
461 Muhammad JS, Saheb Sharif-Askari N, Cui ZG, Hamad M, Halwani R. SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene. Front Genet 2021;12:622271. [PMID: 33679887 DOI: 10.3389/fgene.2021.622271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
462 Rizzo F, Edenborough KM, Toffoli R, Culasso P, Zoppi S, Dondo A, Robetto S, Rosati S, Lander A, Kurth A, Orusa R, Bertolotti L, Mandola ML. Coronavirus and paramyxovirus in bats from Northwest Italy. BMC Vet Res 2017;13:396. [PMID: 29273042 DOI: 10.1186/s12917-017-1307-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
463 Kawachi S, Luong ST, Shigematsu M, Furuya H, Phung TT, Phan PH, Nunoi H, Nguyen LT, Suzuki K. Risk parameters of fulminant acute respiratory distress syndrome and avian influenza (H5N1) infection in Vietnamese children. J Infect Dis 2009;200:510-5. [PMID: 19591579 DOI: 10.1086/605034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
464 Marsden PA, Ning Q, Fung LS, Luo X, Chen Y, Mendicino M, Ghanekar A, Scott JA, Miller T, Chan CW. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest. 2003;112:58-66. [PMID: 12840059 DOI: 10.1172/jci18114] [Cited by in Crossref: 114] [Cited by in F6Publishing: 78] [Article Influence: 6.0] [Reference Citation Analysis]
465 Zheng B, Cao KY, Chan CP, Choi JW, Leung W, Leung M, Duan ZH, Gao Y, Wang M, Di B, Hollidt JM, Bergmann A, Lehmann M, Renneberg I, Tam JS, Chan PK, Cautherley GW, Fuchs D, Renneberg R. Serum neopterin for early assessment of severity of severe acute respiratory syndrome. Clin Immunol 2005;116:18-26. [PMID: 15925828 DOI: 10.1016/j.clim.2005.03.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
466 Zhou P, Fan H, Lan T, Yang XL, Shi WF, Zhang W, Zhu Y, Zhang YW, Xie QM, Mani S, Zheng XS, Li B, Li JM, Guo H, Pei GQ, An XP, Chen JW, Zhou L, Mai KJ, Wu ZX, Li D, Anderson DE, Zhang LB, Li SY, Mi ZQ, He TT, Cong F, Guo PJ, Huang R, Luo Y, Liu XL, Chen J, Huang Y, Sun Q, Zhang XL, Wang YY, Xing SZ, Chen YS, Sun Y, Li J, Daszak P, Wang LF, Shi ZL, Tong YG, Ma JY. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature 2018;556:255-8. [PMID: 29618817 DOI: 10.1038/s41586-018-0010-9] [Cited by in Crossref: 291] [Cited by in F6Publishing: 282] [Article Influence: 72.8] [Reference Citation Analysis]
467 Briguglio I, Piras S, Corona P, Carta A. Inhibition of RNA Helicases of ssRNA(+) Virus Belonging to Flaviviridae, Coronaviridae and Picornaviridae Families. Int J Med Chem 2011;2011:213135. [PMID: 27516903 DOI: 10.1155/2011/213135] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
468 Lin Z, Wang Z, Zhang X, Diao D. Superhydrophobic, photo-sterilize, and reusable mask based on graphene nanosheet-embedded carbon (GNEC) film. Nano Res 2020;:1-14. [PMID: 33250970 DOI: 10.1007/s12274-020-3158-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
469 Tang BS, Chan KH, Cheng VC, Woo PC, Lau SK, Lam CC, Chan TL, Wu AK, Hung IF, Leung SY, Yuen KY. Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. J Virol 2005;79:6180-93. [PMID: 15858003 DOI: 10.1128/JVI.79.10.6180-6193.2005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
470 Teoh KT, Siu YL, Chan WL, Schlüter MA, Liu CJ, Peiris JS, Bruzzone R, Margolis B, Nal B. The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis. Mol Biol Cell 2010;21:3838-52. [PMID: 20861307 DOI: 10.1091/mbc.E10-04-0338] [Cited by in Crossref: 117] [Cited by in F6Publishing: 99] [Article Influence: 9.8] [Reference Citation Analysis]
471 Chan JF, Yip CC, To KK, Tang TH, Wong SC, Leung KH, Fung AY, Ng AC, Zou Z, Tsoi HW, Choi GK, Tam AR, Cheng VC, Chan KH, Tsang OT, Yuen KY. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens. J Clin Microbiol. 2020;58. [PMID: 32132196 DOI: 10.1128/jcm.00310-20] [Cited by in Crossref: 420] [Cited by in F6Publishing: 283] [Article Influence: 210.0] [Reference Citation Analysis]
472 Shieh WJ, Hsiao CH, Paddock CD, Guarner J, Goldsmith CS, Tatti K, Packard M, Mueller L, Wu MZ, Rollin P, Su IJ, Zaki SR. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum Pathol 2005;36:303-9. [PMID: 15791576 DOI: 10.1016/j.humpath.2004.11.006] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 5.4] [Reference Citation Analysis]
473 Charlton CL, Babady E, Ginocchio CC, Hatchette TF, Jerris RC, Li Y, Loeffelholz M, McCarter YS, Miller MB, Novak-Weekley S, Schuetz AN, Tang YW, Widen R, Drews SJ. Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections. Clin Microbiol Rev 2019;32:e00042-18. [PMID: 30541871 DOI: 10.1128/CMR.00042-18] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
474 Mo H, Zeng G, Ren X, Li H, Ke C, Tan Y, Cai C, Lai K, Chen R, Chan-Yeung M, Zhong N. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology 2006;11:49-53. [PMID: 16423201 DOI: 10.1111/j.1440-1843.2006.00783.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 107] [Article Influence: 7.9] [Reference Citation Analysis]
475 Chong PY, Iqbal J, Yeong J, Aw TC, Chan KS, Chui P. Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies. Front Mol Biosci 2021;8:658932. [PMID: 34765640 DOI: 10.3389/fmolb.2021.658932] [Reference Citation Analysis]
476 Lau SK, Woo PC, Yip CC, Tse H, Tsoi HW, Cheng VC, Lee P, Tang BS, Cheung CH, Lee RA, So LY, Lau YL, Chan KH, Yuen KY. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 2006;44:2063-71. [PMID: 16757599 DOI: 10.1128/JCM.02614-05] [Cited by in Crossref: 267] [Cited by in F6Publishing: 196] [Article Influence: 16.7] [Reference Citation Analysis]
477 Zahariadis G, Gooley TA, Ryall P, Hutchinson C, Latchford MI, Fearon MA, Jamieson FB, Richardson S, Kuschak T, Mederski B. Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays. Can Respir J 2006;13:17-22. [PMID: 16470249 DOI: 10.1155/2006/862797] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
478 Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, Choi KW, Tso YK, Lau T, Lai ST, Lai CL. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004;39:302-10. [PMID: 14767982 DOI: 10.1002/hep.20111] [Cited by in Crossref: 261] [Cited by in F6Publishing: 232] [Article Influence: 14.5] [Reference Citation Analysis]
479 Algaissi AA, Alharbi NK, Hassanain M, Hashem AM. Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience. J Infect Public Health 2020;13:834-8. [PMID: 32451260 DOI: 10.1016/j.jiph.2020.04.016] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 36.5] [Reference Citation Analysis]
480 Lee CC, Kuo CJ, Ko TP, Hsu MF, Tsui YC, Chang SC, Yang S, Chen SJ, Chen HC, Hsu MC. Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J Biol Chem. 2009;284:7646-7655. [PMID: 19144641 DOI: 10.1074/jbc.M807947200] [Cited by in Crossref: 83] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
481 Haagmans BL, Osterhaus AD. Coronaviruses and their therapy. Antiviral Res 2006;71:397-403. [PMID: 16837072 DOI: 10.1016/j.antiviral.2006.05.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
482 Bailey-Elkin BA, Knaap RCM, Kikkert M, Mark BL. Structure and Function of Viral Deubiquitinating Enzymes. J Mol Biol 2017;429:3441-70. [PMID: 28625850 DOI: 10.1016/j.jmb.2017.06.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
483 Qian C, Qin D, Tang Q, Zeng Y, Tang G, Lu C. Identification of a B-cell antigenic epitope at the N-terminus of SARS-CoV M protein and characterization of monoclonal antibody against the protein. Virus Genes 2006;33:147-56. [PMID: 16972028 DOI: 10.1007/s11262-005-0050-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
484 Sihoe AD, Wong RH, Lee AT, Lau LS, Leung NY, Law KI, Yim AP. Severe acute respiratory syndrome complicated by spontaneous pneumothorax. Chest 2004;125:2345-51. [PMID: 15189961 DOI: 10.1378/chest.125.6.2345] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
485 Lau SK, Woo PC, Li KS, Zhang HJ, Fan RY, Zhang AJ, Chan BC, Lam CS, Yip CC, Yuen MC, Chan KH, Chen ZW, Yuen KY. Identification of Novel Rosavirus Species That Infects Diverse Rodent Species and Causes Multisystemic Dissemination in Mouse Model. PLoS Pathog 2016;12:e1005911. [PMID: 27737017 DOI: 10.1371/journal.ppat.1005911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
486 Kumar P, Gunalan V, Liu B, Chow VT, Druce J, Birch C, Catton M, Fielding BC, Tan YJ, Lal SK. The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with its ORF6 accessory protein. Virology 2007;366:293-303. [PMID: 17532020 DOI: 10.1016/j.virol.2007.04.029] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
487 Johnson BA, Graham RL, Menachery VD. Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses. Virology 2018;517:30-7. [PMID: 29279138 DOI: 10.1016/j.virol.2017.12.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
488 Risku M, Lappalainen S, Räsänen S, Vesikari T. Detection of human coronaviruses in children with acute gastroenteritis. J Clin Virol 2010;48:27-30. [PMID: 20233673 DOI: 10.1016/j.jcv.2010.02.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
489 Ali MG, Zhang Z, Gao Q, Pan M, Rowan EG, Zhang J. Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview. Immunol Res 2020;68:325-39. [PMID: 33161557 DOI: 10.1007/s12026-020-09159-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
490 Yan Y, Shin WI, Pang YX, Meng Y, Lai J, You C, Zhao H, Lester E, Wu T, Pang CH. The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. Int J Environ Res Public Health. 2020;17. [PMID: 32235575 DOI: 10.3390/ijerph17072323] [Cited by in Crossref: 106] [Cited by in F6Publishing: 83] [Article Influence: 53.0] [Reference Citation Analysis]
491 Lei J, Hilgenfeld R. Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin. Virol Sin 2016;31:288-99. [PMID: 27245450 DOI: 10.1007/s12250-016-3742-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
492 Kwan A, Fok WG, Law KI, Lam SH. Tracheostomy in a patient with severe acute respiratory syndrome. Br J Anaesth 2004;92:280-2. [PMID: 14722185 DOI: 10.1093/bja/aeh035] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
493 Thomas M, Lu JJ, Chen J, Klibanov AM. Non-viral siRNA delivery to the lung. Adv Drug Deliv Rev 2007;59:124-33. [PMID: 17459519 DOI: 10.1016/j.addr.2007.03.003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 4.6] [Reference Citation Analysis]
494 de Almeida SMV, Santos Soares JC, Dos Santos KL, Alves JEF, Ribeiro AG, Jacob ÍTT, da Silva Ferreira CJ, Dos Santos JC, de Oliveira JF, de Carvalho Junior LB, de Lima MDCA. COVID-19 therapy: What weapons do we bring into battle? Bioorg Med Chem 2020;28:115757. [PMID: 32992245 DOI: 10.1016/j.bmc.2020.115757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
495 Navas-Martin S, Hingley ST, Weiss SR. Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein. J Virol 2005;79:7629-40. [PMID: 15919915 DOI: 10.1128/JVI.79.12.7629-7640.2005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
496 Smith EC, Blanc H, Surdel MC, Vignuzzi M, Denison MR. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog. 2013;9:e1003565. [PMID: 23966862 DOI: 10.1371/journal.ppat.1003565] [Cited by in Crossref: 231] [Cited by in F6Publishing: 207] [Article Influence: 25.7] [Reference Citation Analysis]
497 Lee YC, Leu SJ, Hu CJ, Shih NY, Huang IJ, Wu HH, Hsieh WS, Chiang BL, Chiu WT, Yang YY. Chicken single-chain variable fragments against the SARS-CoV spike protein. J Virol Methods 2007;146:104-11. [PMID: 17643500 DOI: 10.1016/j.jviromet.2007.06.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
498 Bivas-Benita M, Ottenhoff TH, Junginger HE, Borchard G. Pulmonary DNA vaccination: concepts, possibilities and perspectives. J Control Release 2005;107:1-29. [PMID: 16054263 DOI: 10.1016/j.jconrel.2005.05.028] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
499 Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, Leung GM, Lam TH, Hedley AJ. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004;359:1091-1105. [PMID: 15306395 DOI: 10.1098/rstb.2004.1490] [Cited by in Crossref: 278] [Cited by in F6Publishing: 234] [Article Influence: 15.4] [Reference Citation Analysis]
500 Kumaki Y, Ennis J, Rahbar R, Turner JD, Wandersee MK, Smith AJ, Bailey KW, Vest ZG, Madsen JR, Li JK, Barnard DL. Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model. Antiviral Res 2011;89:75-82. [PMID: 21093489 DOI: 10.1016/j.antiviral.2010.11.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
501 Yan L, Meng B, Xiang J, Wilson IA, Yang B. Crystal structure of the post-fusion core of the Human coronavirus 229E spike protein at 1.86 Å resolution. Acta Crystallogr D Struct Biol 2018;74:841-51. [PMID: 30198895 DOI: 10.1107/S2059798318008318] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
502 Sutton TC, Subbarao K. Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus. Virology 2015;479-480:247-58. [PMID: 25791336 DOI: 10.1016/j.virol.2015.02.030] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
503 Jones BM, Ma ES, Peiris JS, Wong PC, Ho JC, Lam B, Lai KN, Tsang KW. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Clin Exp Immunol. 2004;135:467-473. [PMID: 15008980 DOI: 10.1111/j.1365-2249.2003.02391.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
504 Tang Q, Li B, Woodle M, Lu PY. Application of siRNA against SARS in the rhesus macaque model. Methods Mol Biol 2008;442:139-58. [PMID: 18369784 DOI: 10.1007/978-1-59745-191-8_11] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
505 Verma RK, Kannaujia S, Khurana N, Singh A, Singh DP, Kumar A. Clinical correlation of severe acute respiratory syndrome-coronavirus-2 cases in selected districts of Uttar Pradesh: A cross-sectional hospital-based study. J Educ Health Promot 2020;9:357. [PMID: 33575393 DOI: 10.4103/jehp.jehp_563_20] [Reference Citation Analysis]
506 Schaecher SR, Mackenzie JM, Pekosz A. The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J Virol 2007;81:718-31. [PMID: 17079322 DOI: 10.1128/JVI.01691-06] [Cited by in Crossref: 101] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
507 Méry G, Epaulard O, Borel AL, Toussaint B, Le Gouellec A. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella. Front Immunol 2020;11:1714. [PMID: 32793244 DOI: 10.3389/fimmu.2020.01714] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
508 Hung EC, Chim SS, Chan PK, Tong YK, Ng EK, Chiu RW, Leung CB, Sung JJ, Tam JS, Lo YM. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem 2003;49:2108-9. [PMID: 14633896 DOI: 10.1373/clinchem.2003.025437] [Cited by in Crossref: 160] [Cited by in F6Publishing: 151] [Article Influence: 8.4] [Reference Citation Analysis]
509 Spruth M, Kistner O, Savidis-Dacho H, Hitter E, Crowe B, Gerencer M, Brühl P, Grillberger L, Reiter M, Tauer C, Mundt W, Barrett PN. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses. Vaccine 2006;24:652-61. [PMID: 16214268 DOI: 10.1016/j.vaccine.2005.08.055] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 4.8] [Reference Citation Analysis]
510 Ding L, Zhang XX, Wei P, Fan K, Lai L. The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis. Anal Biochem 2005;343:159-65. [PMID: 15935325 DOI: 10.1016/j.ab.2005.04.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
511 Yam WC, Chan KH, Chow KH, Poon LL, Lam HY, Yuen KY, Seto WH, Peiris JS. Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods. J Clin Virol 2005;33:19-24. [PMID: 15797361 DOI: 10.1016/j.jcv.2004.09.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
512 Pennington H. Politics, media and microbiologists. Nat Rev Microbiol 2004;2:259-62. [PMID: 15083161 DOI: 10.1038/nrmicro846] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
513 Luo Z, Ang MJY, Chan SY, Yi Z, Goh YY, Yan S, Tao J, Liu K, Li X, Zhang H, Huang W, Liu X. Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community. Research (Wash D C) 2020;2020:6925296. [PMID: 32607499 DOI: 10.34133/2020/6925296] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
514 Jenwitheesuk E, Samudrala R. Identifying inhibitors of the SARS coronavirus proteinase. Bioorg Med Chem Lett 2003;13:3989-92. [PMID: 14592491 DOI: 10.1016/j.bmcl.2003.08.066] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
515 Guan Y, Peiris JS, Zheng B, Poon LL, Chan KH, Zeng FY, Chan CW, Chan MN, Chen JD, Chow KY, Hon CC, Hui KH, Li J, Li VY, Wang Y, Leung SW, Yuen KY, Leung FC. Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome. Lancet 2004;363:99-104. [PMID: 14726162 DOI: 10.1016/s0140-6736(03)15259-2] [Cited by in Crossref: 90] [Cited by in F6Publishing: 68] [Article Influence: 5.0] [Reference Citation Analysis]
516 Mok E, Chung BP, Chung JW, Wong TK. An exploratory study of nurses suffering from severe acute respiratory syndrome (SARS). Int J Nurs Pract. 2005;11:150-160. [PMID: 15985093 DOI: 10.1111/j.1440-172x.2005.00520.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
517 Li AM, Ng PC. Severe acute respiratory syndrome (SARS) in neonates and children. Arch Dis Child Fetal Neonatal Ed 2005;90:F461-5. [PMID: 16244207 DOI: 10.1136/adc.2005.075309] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
518 Struck AW, Axmann M, Pfefferle S, Drosten C, Meyer B. A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2. Antiviral Res. 2012;94:288-296. [PMID: 22265858 DOI: 10.1016/j.antiviral.2011.12.012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
519 Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003;77:8801-11. [PMID: 12885899 DOI: 10.1128/jvi.77.16.8801-8811.2003] [Cited by in Crossref: 777] [Cited by in F6Publishing: 578] [Article Influence: 40.9] [Reference Citation Analysis]
520 Tse H, Tsang AK, Tsoi HW, Leung AS, Ho CC, Lau SK, Woo PC, Yuen KY. Identification of a novel bat papillomavirus by metagenomics. PLoS One 2012;7:e43986. [PMID: 22937142 DOI: 10.1371/journal.pone.0043986] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
521 Chan CP, Siu KL, Chin KT, Yuen KY, Zheng B, Jin DY. Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2006;80:9279-9287. [PMID: 16940539 DOI: 10.1128/jvi.00659-06] [Cited by in Crossref: 122] [Cited by in F6Publishing: 95] [Article Influence: 7.6] [Reference Citation Analysis]
522 Hui RK, Zeng F, Chan CM, Yuen KY, Peiris JS, Leung FC. Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome. J Clin Microbiol 2004;42:1994-9. [PMID: 15131160 DOI: 10.1128/JCM.42.5.1994-1999.2004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
523 Behloul N, Baha S, Shi R, Meng J. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein. Virus Res 2020;286:198058. [PMID: 32531235 DOI: 10.1016/j.virusres.2020.198058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
524 Han DP, Lohani M, Cho MW. Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J Virol 2007;81:12029-39. [PMID: 17715238 DOI: 10.1128/JVI.00315-07] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
525 Twu SJ, Chen TJ, Chen CJ, Olsen SJ, Lee LT, Fisk T, Hsu KH, Chang SC, Chen KT, Chiang IH, Wu YC, Wu JS, Dowell SF. Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis 2003;9:718-20. [PMID: 12781013 DOI: 10.3201/eid0906.030283] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 5.7] [Reference Citation Analysis]
526 Mandell LA. Etiologies of acute respiratory tract infections. Clin Infect Dis 2005;41:503-6. [PMID: 16028159 DOI: 10.1086/432019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
527 Woo PC, Lau SK, Wong BH, Tsoi HW, Fung AM, Chan KH, Tam VK, Peiris JS, Yuen KY. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2004;42:2306-9. [PMID: 15131220 DOI: 10.1128/JCM.42.5.2306-2309.2004] [Cited by in Crossref: 87] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
528 Pormohammad A, Ghorbani S, Khatami A, Farzi R, Baradaran B, Turner DL, Turner RJ, Bahr NC, Idrovo JP. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev Med Virol. 2020;30:e2112. [PMID: 32502331 DOI: 10.1002/rmv.2112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
529 Blanquer Olivas J. [On severe acute respiratory syndrome (SARS): epidemics in the context of globalization]. Arch Bronconeumol 2003;39:243-5. [PMID: 12797937 DOI: 10.1016/s0300-2896(03)75373-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
530 He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun. 2004;324:773-781. [PMID: 15474494 DOI: 10.1016/j.bbrc.2004.09.106] [Cited by in Crossref: 259] [Cited by in F6Publishing: 248] [Article Influence: 14.4] [Reference Citation Analysis]
531 Qing E, Hantak M, Perlman S, Gallagher T. Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection. mBio 2020;11:e02764-19. [PMID: 32047128 DOI: 10.1128/mBio.02764-19] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 23.5] [Reference Citation Analysis]
532 Wathelet MG, Orr M, Frieman MB, Baric RS. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J Virol 2007;81:11620-33. [PMID: 17715225 DOI: 10.1128/JVI.00702-07] [Cited by in Crossref: 223] [Cited by in F6Publishing: 173] [Article Influence: 14.9] [Reference Citation Analysis]
533 Roberton SI, Bell DJ, Smith GJ, Nicholls JM, Chan KH, Nguyen DT, Tran PQ, Streicher U, Poon LL, Chen H, Horby P, Guardo M, Guan Y, Peiris JS. Avian influenza H5N1 in viverrids: implications for wildlife health and conservation. Proc Biol Sci 2006;273:1729-32. [PMID: 16790404 DOI: 10.1098/rspb.2006.3549] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
534 Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, Choi KW, Tso YK, Lau T, Lai ST, Lai CL. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004;39:302-10. [PMID: 14767982 DOI: 10.1002/hep.20111] [Reference Citation Analysis]
535 Wang Q, Li C, Zhang Q, Wang T, Li J, Guan W, Yu J, Liang M, Li D. Interactions of SARS coronavirus nucleocapsid protein with the host cell proteasome subunit p42. Virol J 2010;7:99. [PMID: 20478047 DOI: 10.1186/1743-422X-7-99] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
536 Reghunathan R, Jayapal M, Hsu LY, Chng HH, Tai D, Leung BP, Melendez AJ. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol 2005;6:2. [PMID: 15655079 DOI: 10.1186/1471-2172-6-2] [Cited by in Crossref: 182] [Cited by in F6Publishing: 186] [Article Influence: 10.7] [Reference Citation Analysis]
537 Du L, Kao RY, Zhou Y, He Y, Zhao G, Wong C, Jiang S, Yuen KY, Jin DY, Zheng BJ. Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity. Biochem Biophys Res Commun 2007;359:174-9. [PMID: 17533109 DOI: 10.1016/j.bbrc.2007.05.092] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 5.2] [Reference Citation Analysis]
538 Buller RS, Arens MQ. Molecular Detection of Respiratory Viruses. In: Persing DH, Tenover FC, Tang Y, Nolle FS, Hayden RT, van Belkum A, editors. Molecular Microbiology. Wiley; 2011. pp. 605-30. [DOI: 10.1128/9781555816834.ch39] [Reference Citation Analysis]
539 Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, Wong SS, Leung SY, Chan KH, Yuen KY. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A 2005;102:14040-5. [PMID: 16169905 DOI: 10.1073/pnas.0506735102] [Cited by in Crossref: 976] [Cited by in F6Publishing: 879] [Article Influence: 57.4] [Reference Citation Analysis]
540 Lin K, Yee-Tak Fong D, Zhu B, Karlberg J. Environmental factors on the SARS epidemic: air temperature, passage of time and multiplicative effect of hospital infection. Epidemiol Infect 2006;134:223-30. [PMID: 16490124 DOI: 10.1017/S0950268805005054] [Cited by in Crossref: 82] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
541 Al-Osail AM, Al-Wazzah MJ. The history and epidemiology of Middle East respiratory syndrome corona virus. Multidiscip Respir Med 2017;12:20. [PMID: 28794876 DOI: 10.1186/s40248-017-0101-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
542 He Z, Dong Q, Zhuang H, Song S, Peng G, Luo G, Dwyer DE. Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS. Clin Diagn Lab Immunol 2004;11:792-4. [PMID: 15242960 DOI: 10.1128/CDLI.11.4.792-794.2004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
543 Chen W, Xu Z, Mu J, He B, Yang L, Lin L, Meng S, Mu F, Gan H, Huang S, Wen J, Fang J, Wang J. Real-time quantitative fluorescent reverse transcriptase-PCR for detection of severe acute respiratory syndrome-associated coronavirus RNA. Mol Diagn 2004;8:231-5. [PMID: 15887978 DOI: 10.1007/BF03260067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
544 Wu YP, Liu ZH, Wei R, Pan SD, Mao NY, Chen B, Han JJ, Zhang FS, Holmskov U, Xia ZL, de Groot PG, Reid KB, Xu WB, Sorensen GL. Elevated plasma surfactant protein D (SP-D) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific IgG antibody in SARS patients. Scand J Immunol 2009;69:508-15. [PMID: 19439011 DOI: 10.1111/j.1365-3083.2009.02245.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
545 Stoltz M, Ahlm C, Lundkvist A, Klingström J. Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production. J Virol 2007;81:8685-91. [PMID: 17522204 DOI: 10.1128/JVI.00415-07] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
546 Pearson H, Clarke T, Abbott A, Knight J, Cyranoski D. SARS: what have we learned? Nature 2003;424:121-6. [PMID: 12853923 DOI: 10.1038/424121a] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
547 Chen A, Huang JX, Liao Y, Liu Z, Chen D, Yang C, Yang RM, Wei X. Differences in Clinical and Imaging Presentation of Pediatric Patients with COVID-19 in Comparison with Adults. Radiol Cardiothorac Imaging 2020;2:e200117. [PMID: 33778567 DOI: 10.1148/ryct.2020200117] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
548 Chen CY, Lee CH, Liu CY, Wang JH, Wang LM, Perng RP. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc. 2005;68:4-10. [PMID: 15742856 DOI: 10.1016/s1726-4901(09)70124-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
549 Mallick Gupta A, Mandal S, Mandal S, Chakrabarti J. Immune escape facilitation by mutations of epitope residues in RdRp of SARS-CoV-2. J Biomol Struct Dyn 2022;:1-11. [PMID: 35293850 DOI: 10.1080/07391102.2022.2051746] [Reference Citation Analysis]
550 Zhang X, Wu K, Yue X, Zhu Y, Wu J. Inhibition of SARS-CoV gene expression by adenovirus-delivered small hairpin RNA. Intervirology 2007;50:63-70. [PMID: 17139181 DOI: 10.1159/000097391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
551 Álvarez E, Donado-Campos J, Morilla F. New coronavirus outbreak. Lessons learned from the severe acute respiratory syndrome epidemic. Epidemiol Infect 2015;143:2882-93. [PMID: 25591619 DOI: 10.1017/S095026881400377X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
552 Sandrock C, Stollenwerk N. Acute febrile respiratory illness in the ICU: reducing disease transmission. Chest 2008;133:1221-31. [PMID: 18460521 DOI: 10.1378/chest.07-0778] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
553 Wu S, Xu J, Liu J, Yan X, Zhu X, Xiao G, Sun L, Tien P. An efficient RNA-cleaving DNA enzyme can specifically target the 5'-untranslated region of severe acute respiratory syndrome associated coronavirus (SARS-CoV). J Gene Med 2007;9:1080-6. [PMID: 17966113 DOI: 10.1002/jgm.1111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
554 Yang H, Xie W, Xue X, Yang K, Ma J, Liang W, Zhao Q, Zhou Z, Pei D, Ziebuhr J. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 2005;3:e324. [PMID: 16128623 DOI: 10.1371/journal.pbio.0030324] [Cited by in Crossref: 260] [Cited by in F6Publishing: 285] [Article Influence: 15.3] [Reference Citation Analysis]
555 Brooks EF, Bhatt AS. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19? Cold Spring Harb Mol Case Stud 2021;7:a006031. [PMID: 33593727 DOI: 10.1101/mcs.a006031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
556 Pyrc K, Sims AC, Dijkman R, Jebbink M, Long C, Deming D, Donaldson E, Vabret A, Baric R, van der Hoek L. Culturing the unculturable: human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures. J Virol. 2010;84:11255-11263. [PMID: 20719951 DOI: 10.1128/jvi.00947-10] [Cited by in Crossref: 89] [Cited by in F6Publishing: 74] [Article Influence: 7.4] [Reference Citation Analysis]
557 Kenu E, Odikro MA, Malm KL, Asiedu-Bekoe F, Noora CL, Frimpong JA, Calys-Tagoe B, Koram KA. Epidemiology of COVID-19 outbreak in Ghana, 2020. Ghana Med J 2020;54:5-15. [PMID: 33976436 DOI: 10.4314/gmj.v54i4s.3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
558 Liu W, Tang F, Fontanet A, Zhan L, Zhao QM, Zhang PH, Wu XM, Zuo SQ, Baril L, Vabret A, Xin ZT, Shao YM, Yang H, Cao WC. Long-term SARS coronavirus excretion from patient cohort, China. Emerg Infect Dis 2004;10:1841-3. [PMID: 15504274 DOI: 10.3201/eid1010.040297] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
559 Barkham TM, Chung YK, Tang KF, Ooi EE. The performance of RT-PCR compared with a rapid serological assay for acute dengue fever in a diagnostic laboratory. Trans R Soc Trop Med Hyg 2006;100:142-8. [PMID: 16212996 DOI: 10.1016/j.trstmh.2005.05.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
560 Chan PK, To WK, Ng KC, Lam RK, Ng TK, Chan RC, Wu A, Yu WC, Lee N, Hui DS, Lai ST, Hon EK, Li CK, Sung JJ, Tam JS. Laboratory diagnosis of SARS. Emerg Infect Dis 2004;10:825-31. [PMID: 15200815 DOI: 10.3201/eid1005.030682] [Cited by in Crossref: 104] [Cited by in F6Publishing: 89] [Article Influence: 5.8] [Reference Citation Analysis]
561 Zhao JC, Zhao ZD, Wang W, Gao XM. Prokaryotic expression, refolding, and purification of fragment 450-650 of the spike protein of SARS-coronavirus. Protein Expr Purif 2005;39:169-74. [PMID: 15642467 DOI: 10.1016/j.pep.2004.10.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
562 Nicholls J, Dong XP, Jiang G, Peiris M. SARS: clinical virology and pathogenesis. Respirology 2003;8 Suppl:S6-8. [PMID: 15018126 DOI: 10.1046/j.1440-1843.2003.00517.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.0] [Reference Citation Analysis]
563 Jamieson DJ, Ellis JE, Jernigan DB, Treadwell TA. Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician-gynecologists. Am J Obstet Gynecol 2006;194:1546-55. [PMID: 16731070 DOI: 10.1016/j.ajog.2005.06.062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
564 Lau SKP, Zhang L, Luk HKH, Xiong L, Peng X, Li KSM, He X, Zhao PS, Fan RYY, Wong ACP, Ahmed SS, Cai JP, Chan JFW, Sun Y, Jin D, Chen H, Lau TCK, Kok RKH, Li W, Yuen KY, Woo PCY. Receptor Usage of a Novel Bat Lineage C Betacoronavirus Reveals Evolution of Middle East Respiratory Syndrome-Related Coronavirus Spike Proteins for Human Dipeptidyl Peptidase 4 Binding. J Infect Dis 2018;218:197-207. [PMID: 29346682 DOI: 10.1093/infdis/jiy018] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 16.7] [Reference Citation Analysis]
565 Riguzzi M, Gashi S. Lessons From the First Wave of COVID-19: Work-Related Consequences, Clinical Knowledge, Emotional Distress, and Safety-Conscious Behavior in Healthcare Workers in Switzerland. Front Psychol 2021;12:628033. [PMID: 33633652 DOI: 10.3389/fpsyg.2021.628033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
566 Kumaki Y, Day CW, Wandersee MK, Schow BP, Madsen JS, Grant D, Roth JP, Smee DF, Blatt LM, Barnard DL. Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells. Biochem Biophys Res Commun 2008;371:110-3. [PMID: 18406349 DOI: 10.1016/j.bbrc.2008.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
567 Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, Stöhr K, Osterhaus AD. Aetiology: Koch's postulates fulfilled for SARS virus. Nature. 2003;423:240. [PMID: 12748632 DOI: 10.1038/423240a] [Cited by in Crossref: 566] [Cited by in F6Publishing: 537] [Article Influence: 29.8] [Reference Citation Analysis]
568 Atif M, Malik I. Why is Pakistan vulnerable to COVID-19 associated morbidity and mortality? A scoping review. Int J Health Plann Manage 2020;35:1041-54. [PMID: 32700410 DOI: 10.1002/hpm.3016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
569 Elhamzaoui H, Rebahi H, Hachimi A. Coronavirus disease 2019 (COVID-19) pathogenesis: a concise narrative review. Pan Afr Med J 2021;39:8. [PMID: 34178236 DOI: 10.11604/pamj.2021.39.8.23546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
570 Ram S. Coronavirus Research Trends: A 50–Year Bibliometric Assessment. Science & Technology Libraries 2020;39:210-26. [DOI: 10.1080/0194262x.2020.1742270] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 8.5] [Reference Citation Analysis]
571 Wong SF, Chow KM, Shek CC, Leung YP, Chiu A, Lam PW, Ho LC. Measures to prevent healtcare workers from contracting severe acute respiratory syndrome during high-risk surgical procedures. Eur J Clin Microbiol Infect Dis 2004;23:131-3. [PMID: 14712366 DOI: 10.1007/s10096-003-1068-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
572 de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523-534. [PMID: 27344959 DOI: 10.1038/nrmicro.2016.81] [Cited by in Crossref: 1666] [Cited by in F6Publishing: 1484] [Article Influence: 277.7] [Reference Citation Analysis]
573 Cheng VC, Hung IF, Tang BS, Chu CM, Wong MM, Chan KH, Wu AK, Tse DM, Chan KS, Zheng BJ, Peiris JS, Sung JJ, Yuen KY. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin Infect Dis 2004;38:467-75. [PMID: 14765337 DOI: 10.1086/382681] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 3.9] [Reference Citation Analysis]
574 Müller C, Hardt M, Schwudke D, Neuman BW, Pleschka S, Ziebuhr J. Inhibition of Cytosolic Phospholipase A2α Impairs an Early Step of Coronavirus Replication in Cell Culture. J Virol 2018;92:e01463-17. [PMID: 29167338 DOI: 10.1128/JVI.01463-17] [Cited by in Crossref: 33] [Cited by in F6Publishing: 42] [Article Influence: 8.3] [Reference Citation Analysis]
575 Seto WH, Tsang D, Yung RW, Ching TY, Ng TK, Ho M, Ho LM, Peiris JS; Advisors of Expert SARS group of Hospital Authority. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet. 2003;361:1519-1520. [PMID: 12737864 DOI: 10.1016/s0140-6736(03)13168-6] [Cited by in Crossref: 525] [Cited by in F6Publishing: 325] [Article Influence: 27.6] [Reference Citation Analysis]
576 Hilgenfeld R. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J 2014;281:4085-96. [PMID: 25039866 DOI: 10.1111/febs.12936] [Cited by in Crossref: 267] [Cited by in F6Publishing: 244] [Article Influence: 33.4] [Reference Citation Analysis]
577 Lan YC, Liu HF, Shih YP, Yang JY, Chen HY, Chen YM. Phylogenetic analysis and sequence comparisons of structural and non-structural SARS coronavirus proteins in Taiwan. Infect Genet Evol 2005;5:261-9. [PMID: 15737918 DOI: 10.1016/j.meegid.2004.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
578 Samaranayake LP, Peiris M. Severe acute respiratory syndrome and dentistry: a retrospective view. J Am Dent Assoc 2004;135:1292-302. [PMID: 15493394 DOI: 10.14219/jada.archive.2004.0405] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
579 Ramajayam R, Tan KP, Liu HG, Liang PH. Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease. Bioorg Med Chem Lett 2010;20:3569-72. [PMID: 20494577 DOI: 10.1016/j.bmcl.2010.04.118] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
580 Maxwell C, McGeer A, Tai KFY, Sermer M. No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS). J Obstet Gynaecol Can. 2017;39:e130-e137. [PMID: 28729104 DOI: 10.1016/j.jogc.2017.04.024] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 16.3] [Reference Citation Analysis]
581 Liu YC, Huang V, Chao TC, Hsiao CD, Lin A, Chang MF, Chow LP. Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease. Biochem Biophys Res Commun 2005;333:194-9. [PMID: 15950190 DOI: 10.1016/j.bbrc.2005.05.095] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
582 Zhong NS, Wong GW. Epidemiology of severe acute respiratory syndrome (SARS): adults and children. Paediatr Respir Rev 2004;5:270-4. [PMID: 15531250 DOI: 10.1016/j.prrv.2004.07.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
583 Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol 2021;19:425-41. [PMID: 33824495 DOI: 10.1038/s41579-021-00542-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
584 Mak IW, Chu CM, Pan PC, Yiu MG, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry 2009;31:318-26. [PMID: 19555791 DOI: 10.1016/j.genhosppsych.2009.03.001] [Cited by in Crossref: 417] [Cited by in F6Publishing: 360] [Article Influence: 32.1] [Reference Citation Analysis]
585 Nagata N, Iwata N, Hasegawa H, Fukushi S, Harashima A, Sato Y, Saijo M, Taguchi F, Morikawa S, Sata T. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am J Pathol 2008;172:1625-37. [PMID: 18467696 DOI: 10.2353/ajpath.2008.071060] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
586 Niedrig M, Leitmeyer K, Lim W, Peiris M, Mackenzie JS, Zambon M. First external quality assurance of antibody diagnostic for SARS-new coronavirus. J Clin Virol 2005;34:22-5. [PMID: 16087120 DOI: 10.1016/j.jcv.2005.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
587 Woo PC, Lau SK, Tsoi HW, Chen ZW, Wong BH, Zhang L, Chan JK, Wong LP, He W, Ma C, Chan KH, Ho DD, Yuen KY. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine 2005;23:4959-68. [PMID: 15993989 DOI: 10.1016/j.vaccine.2005.05.023] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
588 Amawi H, Abu Deiab GI, A Aljabali AA, Dua K, Tambuwala MM. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Ther Deliv 2020;11:245-68. [PMID: 32397911 DOI: 10.4155/tde-2020-0035] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 24.5] [Reference Citation Analysis]
589 Woo PC, Lau SK, Huang Y, Tsoi HW, Chan KH, Yuen KY. Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia. Arch Virol 2005;150:2299-311. [PMID: 15986174 DOI: 10.1007/s00705-005-0573-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
590 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(1): 233-235 [DOI: 10.11569/wcjd.v12.i1.233] [Reference Citation Analysis]
591 Kohyama S, Ohno S, Suda T, Taneichi M, Yokoyama S, Mori M, Kobayashi A, Hayashi H, Uchida T, Matsui M. Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a. Antiviral Res 2009;84:168-77. [PMID: 19748524 DOI: 10.1016/j.antiviral.2009.09.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
592 Hsieh YC, Li HC, Chen SC, Lo SY. Interactions between M protein and other structural proteins of severe, acute respiratory syndrome-associated coronavirus. J Biomed Sci 2008;15:707-17. [PMID: 18792806 DOI: 10.1007/s11373-008-9278-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
593 Orenstein JM, Banach B, Baker SC. Morphogenesis of Coronavirus HCoV-NL63 in Cell Culture: A Transmission Electron Microscopic Study. Open Infect Dis J 2008;2:52-8. [PMID: 19844604 DOI: 10.2174/1874279300802010052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
594 Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells. 2020;9. [PMID: 32660065 DOI: 10.3390/cells9071652] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 34.0] [Reference Citation Analysis]
595 Veiga S, Yuan Y, Li X, Santos NC, Liu G, Castanho MA. Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions. Biochim Biophys Acta 2006;1760:55-61. [PMID: 16290276 DOI: 10.1016/j.bbagen.2005.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
596 Roberts A, Paddock C, Vogel L, Butler E, Zaki S, Subbarao K. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol 2005;79:5833-8. [PMID: 15827197 DOI: 10.1128/JVI.79.9.5833-5838.2005] [Cited by in Crossref: 151] [Cited by in F6Publishing: 126] [Article Influence: 8.9] [Reference Citation Analysis]
597 Fujii T, Nakamura T, Iwamoto A. Current concepts in SARS treatment. J Infect Chemother 2004;10:1-7. [PMID: 14991510 DOI: 10.1007/s10156-003-0296-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
598 He Y, Li J, Du L, Yan X, Hu G, Zhou Y, Jiang S. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine. Vaccine. 2006;24:5498-5508. [PMID: 16725238 DOI: 10.1016/j.vaccine.2006.04.054] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
599 Woo PC, Lau SK, Wong BH, Chan KH, Hui WT, Kwan GS, Peiris JS, Couch RB, Yuen KY. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol 2004;42:5885-8. [PMID: 15583332 DOI: 10.1128/JCM.42.12.5885-5888.2004] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
600 Timen A, van Doornum GJ, Schutten M, Conyn-van Spaendonck MA, van der Meer JW, Osterhaus AD, van Steenbergen JE. Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak. Clin Microbiol Infect 2006;12:1214-20. [PMID: 17121628 DOI: 10.1111/j.1469-0691.2006.01552.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
601 File TM Jr, Tsang KW. Severe acute respiratory syndrome: pertinent clinical characteristics and therapy. Treat Respir Med 2005;4:95-106. [PMID: 15813661 DOI: 10.2165/00151829-200504020-00003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
602 Marzi A, Gramberg T, Simmons G, Möller P, Rennekamp AJ, Krumbiegel M, Geier M, Eisemann J, Turza N, Saunier B, Steinkasserer A, Becker S, Bates P, Hofmann H, Pöhlmann S. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 2004;78:12090-5. [PMID: 15479853 DOI: 10.1128/JVI.78.21.12090-12095.2004] [Cited by in Crossref: 256] [Cited by in F6Publishing: 181] [Article Influence: 14.2] [Reference Citation Analysis]
603 Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY;  HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-1772. [PMID: 12781535 DOI: 10.1016/s0140-6736(03)13412-5] [Cited by in Crossref: 1509] [Cited by in F6Publishing: 1111] [Article Influence: 79.4] [Reference Citation Analysis]
604 Li F. Receptor recognition mechanisms of coronaviruses: a decade of structural studies. J Virol 2015;89:1954-64. [PMID: 25428871 DOI: 10.1128/JVI.02615-14] [Cited by in Crossref: 291] [Cited by in F6Publishing: 230] [Article Influence: 36.4] [Reference Citation Analysis]
605 Su CP, Chiang WC, Ma MH, Chen SY, Hsu CY, Ko PC, Tsai KC, Fan CM, Shih FY, Chen SC, Chen YC, Chang SC, Chen WJ. Validation of a novel severe acute respiratory syndrome scoring system. Ann Emerg Med 2004;43:34-42. [PMID: 14707938 DOI: 10.1016/j.annemergmed.2003.10.042] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
606 Kuri T, Zhang X, Habjan M, Martínez-Sobrido L, García-Sastre A, Yuan Z, Weber F. Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J Gen Virol 2009;90:2686-94. [PMID: 19625461 DOI: 10.1099/vir.0.013599-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
607 Mazzulli T, Farcas GA, Poutanen SM, Willey BM, Low DE, Butany J, Asa SL, Kain KC. Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004;10:20-4. [PMID: 15078592 DOI: 10.3201/eid1001.030404] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
608 Zhao K, Yang B, Xu Y, Wu C. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein. Vaccine 2010;28:6666-74. [PMID: 20709007 DOI: 10.1016/j.vaccine.2010.08.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
609 Welker A, Kersten C, Müller C, Madhugiri R, Zimmer C, Müller P, Zimmermann R, Hammerschmidt S, Maus H, Ziebuhr J, Sotriffer C, Schirmeister T. Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2. ChemMedChem 2021;16:340-54. [PMID: 32930481 DOI: 10.1002/cmdc.202000548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
610 Chen Z, Wang Y, Ratia K, Mesecar AD, Wilkinson KD, Baker SC. Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. J Virol 2007;81:6007-18. [PMID: 17392370 DOI: 10.1128/JVI.02747-06] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
611 Danesh F, Dastani M, Ghorbani M. Retrospective and prospective approaches of coronavirus publications in the last half-century: a Latent Dirichlet allocation analysis. LHT 2021;39:855-72. [DOI: 10.1108/lht-09-2020-0216] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
612 Chan KH, Cheng VC, Woo PC, Lau SK, Poon LL, Guan Y, Seto WH, Yuen KY, Peiris JS. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol 2005;12:1317-21. [PMID: 16275947 DOI: 10.1128/CDLI.12.11.1317-1321.2005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
613 Fu HZ, Ho YS. Independent research of China in Science Citation Index Expanded during 1980-2011. J Informetr 2013;7:210-22. [PMID: 32288781 DOI: 10.1016/j.joi.2012.11.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
614 Lau LT, Fung YW, Wong FP, Lin SS, Wang CR, Li HL, Dillon N, Collins RA, Tam JS, Chan PK, Wang CG, Yu AC. A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification. Biochem Biophys Res Commun 2003;312:1290-6. [PMID: 14652014 DOI: 10.1016/j.bbrc.2003.11.064] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
615 Shin GC, Chung YS, Kim IS, Cho HW, Kang C. Antigenic characterization of severe acute respiratory syndrome-coronavirus nucleocapsid protein expressed in insect cells: The effect of phosphorylation on immunoreactivity and specificity. Virus Res 2007;127:71-80. [PMID: 17499376 DOI: 10.1016/j.virusres.2007.03.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
616 Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein. Virus Res 2006;120:146-55. [PMID: 16616792 DOI: 10.1016/j.virusres.2006.03.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
617 Hemida MG. The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2. J Med Virol 2021;93:4219-41. [PMID: 33751621 DOI: 10.1002/jmv.26926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
618 Lyu K, Chow EY, Mou X, Chan TF, Kwok CK. RNA G-quadruplexes (rG4s): genomics and biological functions. Nucleic Acids Res 2021;49:5426-50. [PMID: 33772593 DOI: 10.1093/nar/gkab187] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
619 Wille M, Wensman JJ, Larsson S, van Damme R, Theelke AK, Hayer J, Malmberg M. Evolutionary genetics of canine respiratory coronavirus and recent introduction into Swedish dogs. Infect Genet Evol 2020;82:104290. [PMID: 32205264 DOI: 10.1016/j.meegid.2020.104290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
620 Gomersall CD, Joynt GM, Lam P, Li T, Yap F, Lam D, Buckley TA, Sung JJ, Hui DS, Antonio GE, Ahuja AT, Leung P. Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med 2004;30:381-7. [PMID: 14740156 DOI: 10.1007/s00134-003-2143-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
621 Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, Lei HY. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2005;75:185-194. [PMID: 15602737 DOI: 10.1002/jmv.20255] [Cited by in Crossref: 406] [Cited by in F6Publishing: 387] [Article Influence: 23.9] [Reference Citation Analysis]
622 Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, Dong X, Zhang X, Gao X, Zhu Y, He F. Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005;192:1355-61. [PMID: 16170752 DOI: 10.1086/491479] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 5.5] [Reference Citation Analysis]
623 Sainz B Jr, Mossel EC, Peters CJ, Garry RF. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology. 2004;329:11-17. [PMID: 15476870 DOI: 10.1016/j.virol.2004.08.011] [Cited by in Crossref: 110] [Cited by in F6Publishing: 114] [Article Influence: 6.1] [Reference Citation Analysis]
624 Okada M, Takemoto Y, Okuno Y, Hashimoto S, Fukunaga Y, Tanaka T, Kita Y, Kuwayama S, Muraki Y, Kanamaru N, Takai H, Okada C, Sakaguchi Y, Furukawa I, Yamada K, Izumiya M, Yoshida S, Matsumoto M, Kase T, Peiris JS, DeMello DE, Chen PJ, Yamamoto N, Yoshinaka Y, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M. Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models. Adv Exp Med Biol 2006;581:561-6. [PMID: 17037598 DOI: 10.1007/978-0-387-33012-9_102] [Reference Citation Analysis]
625 Wong SS, Yuen KY. The severe acute respiratory syndrome (SARS). J Neurovirol 2005;11:455-68. [PMID: 16287687 DOI: 10.1080/13550280500187724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
626 Roberts A, Vogel L, Guarner J, Hayes N, Murphy B, Zaki S, Subbarao K. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol 2005;79:503-11. [PMID: 15596843 DOI: 10.1128/JVI.79.1.503-511.2005] [Cited by in Crossref: 179] [Cited by in F6Publishing: 136] [Article Influence: 10.5] [Reference Citation Analysis]
627 Szelazek B, Kabala W, Kus K, Zdzalik M, Twarda-Clapa A, Golik P, Burmistrz M, Florek D, Wladyka B, Pyrc K, Dubin G. Structural Characterization of Human Coronavirus NL63 N Protein. J Virol 2017;91:e02503-16. [PMID: 28331093 DOI: 10.1128/JVI.02503-16] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
628 Ren Y, Zhou Z, Liu J, Lin L, Li S, Wang H, Xia J, Zhao Z, Wen J, Zhou C, Wang J, Yin J, Xu N, Liu S. A strategy for searching antigenic regions in the SARS-CoV spike protein. Genomics Proteomics Bioinformatics 2003;1:207-15. [PMID: 15629033 DOI: 10.1016/s1672-0229(03)01026-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
629 Wong PN, Mak SK, Lo KY, Tong GM, Wong Y, Watt CL, Wong AK. Clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients. Am J Kidney Dis 2003;42:1075-81. [PMID: 14582052 DOI: 10.1016/j.ajkd.2003.08.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
630 Prabakaran P, Zhu Z, Xiao X, Biragyn A, Dimitrov AS, Broder CC, Dimitrov DS. Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. Expert Opin Biol Ther 2009;9:355-68. [PMID: 19216624 DOI: 10.1517/14712590902763755] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
631 Hsu JT, Kuo CJ, Hsieh HP, Wang YC, Huang KK, Lin CP, Huang PF, Chen X, Liang PH. Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV. FEBS Lett 2004;574:116-20. [PMID: 15358550 DOI: 10.1016/j.febslet.2004.08.015] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 3.2] [Reference Citation Analysis]
632 Darbeheshti F, Mahdiannasser M, Uhal BD, Ogino S, Gupta S, Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus. Rev Med Virol 2021;:e2189. [PMID: 33724604 DOI: 10.1002/rmv.2234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
633 Lu Y, Wang S, Zhang L, Xu C, Bian C, Wang Z, Ma Y, Wang K, Ma L, Meng C, Ni C, Tong J, Li G, Han J. Epidemiology of human respiratory viruses in children with acute respiratory tract infections in Jinan, China. Clin Dev Immunol 2013;2013:210490. [PMID: 24363757 DOI: 10.1155/2013/210490] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
634 Petit CM, Chouljenko VN, Iyer A, Colgrove R, Farzan M, Knipe DM, Kousoulas KG. Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. Virology 2007;360:264-74. [PMID: 17134730 DOI: 10.1016/j.virol.2006.10.034] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 4.7] [Reference Citation Analysis]
635 Holmes KV. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest 2003;111:1605-9. [PMID: 12782660 DOI: 10.1172/JCI18819] [Cited by in Crossref: 130] [Cited by in F6Publishing: 112] [Article Influence: 6.8] [Reference Citation Analysis]
636 Kuo CJ, Chao TL, Kao HC, Tsai YM, Liu YK, Wang LH, Hsieh MC, Chang SY, Liang PH. Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2. Antimicrob Agents Chemother 2021;65:e02577-20. [PMID: 33526482 DOI: 10.1128/AAC.02577-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
637 Woo PC, Lau SK, Lam CS, Lai KK, Huang Y, Lee P, Luk GS, Dyrting KC, Chan KH, Yuen KY. Comparative analysis of complete genome sequences of three avian coronaviruses reveals a novel group 3c coronavirus. J Virol 2009;83:908-17. [PMID: 18971277 DOI: 10.1128/JVI.01977-08] [Cited by in Crossref: 149] [Cited by in F6Publishing: 106] [Article Influence: 10.6] [Reference Citation Analysis]
638 Barnard DL, Day CW, Bailey K, Heiner M, Montgomery R, Lauridsen L, Jung KH, Li JK, Chan PK, Sidwell RW. Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model. Antiviral Res 2008;79:105-13. [PMID: 18423639 DOI: 10.1016/j.antiviral.2007.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
639 Mulabbi EN, Tweyongyere R, Byarugaba DK. The history of the emergence and transmission of human coronaviruses. Onderstepoort Journal of Veterinary Research 2020;87. [DOI: 10.4102/ojvr.v87i1.1872] [Reference Citation Analysis]
640 Tanner JA, Watt RM, Chai YB, Lu LY, Lin MC, Peiris JS, Poon LL, Kung HF, Huang JD. The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases. J Biol Chem 2003;278:39578-82. [PMID: 12917423 DOI: 10.1074/jbc.C300328200] [Cited by in Crossref: 122] [Cited by in F6Publishing: 87] [Article Influence: 6.4] [Reference Citation Analysis]
641 Woo PC, Lau SK, Fan RY, Lau CC, Wong EY, Joseph S, Tsang AK, Wernery R, Yip CC, Tsang CC, Wernery U, Yuen KY. Isolation and Characterization of Dromedary Camel Coronavirus UAE-HKU23 from Dromedaries of the Middle East: Minimal Serological Cross-Reactivity between MERS Coronavirus and Dromedary Camel Coronavirus UAE-HKU23. Int J Mol Sci 2016;17:E691. [PMID: 27164099 DOI: 10.3390/ijms17050691] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
642 Broer R, Boson B, Spaan W, Cosset FL, Corver J. Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry. J Virol 2006;80:1302-10. [PMID: 16415007 DOI: 10.1128/JVI.80.3.1302-1310.2006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
643 Agafonov AP, Gus'kov AA, Ternovoi VA, Ryabchikova EI, Durymanov AG, Vinogradov IV, Maksimov NL, Ignat'ev GM, Nechaeva EA, Netesov SV. Primary characterization of SARS coronavirus strain Frankfurt 1. Dokl Biol Sci 2004;394:58-60. [PMID: 15088406 DOI: 10.1023/b:dobs.0000017131.06970.74] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
644 Lau SKP, Wong EYM, Tsang CC, Ahmed SS, Au-Yeung RKH, Yuen KY, Wernery U, Woo PCY. Discovery and Sequence Analysis of Four Deltacoronaviruses from Birds in the Middle East Reveal Interspecies Jumping with Recombination as a Potential Mechanism for Avian-to-Avian and Avian-to-Mammalian Transmission. J Virol 2018;92:e00265-18. [PMID: 29769348 DOI: 10.1128/JVI.00265-18] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
645 Lavi E, Cong L. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp Mol Pathol 2020;115:104474. [PMID: 32454103 DOI: 10.1016/j.yexmp.2020.104474] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
646 Xue X, Yang H, Shen W, Zhao Q, Li J, Yang K, Chen C, Jin Y, Bartlam M, Rao Z. Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction. J Mol Biol 2007;366:965-75. [PMID: 17189639 DOI: 10.1016/j.jmb.2006.11.073] [Cited by in Crossref: 132] [Cited by in F6Publishing: 111] [Article Influence: 8.3] [Reference Citation Analysis]
647 Ooi GC, Daqing M. SARS: radiological features. Respirology 2003;8 Suppl:S15-9. [PMID: 15018128 DOI: 10.1046/j.1440-1843.2003.00519.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
648 Wong T, Wallington T, McDonald LC, Abbas Z, Christian M, Low DE, Gravel D, Ofner M, Mederski B, Berger L, Hansen L, Harrison C, King A, Yaffe B, Tam T. Late recognition of SARS in nosocomial outbreak, Toronto. Emerg Infect Dis 2005;11:322-5. [PMID: 15752456 DOI: 10.3201/eid1102.040607] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
649 Chu H, Chan CM, Zhang X, Wang Y, Yuan S, Zhou J, Au-Yeung RK, Sze KH, Yang D, Shuai H, Hou Y, Li C, Zhao X, Poon VK, Leung SP, Yeung ML, Yan J, Lu G, Jin DY, Gao GF, Chan JF, Yuen KY. Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells. J Biol Chem 2018;293:11709-26. [PMID: 29887526 DOI: 10.1074/jbc.RA118.001897] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 21.0] [Reference Citation Analysis]
650 Lau AC, So LK, Miu FP, Yung RW, Poon E, Cheung TM, Yam LY. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol. Respirology. 2004;9:173-183. [PMID: 15182266 DOI: 10.1111/j.1440-1843.2004.00588.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
651 Lau AT, Chiu JF. Biomarkers of lung-related diseases: current knowledge by proteomic approaches. J Cell Physiol 2009;221:535-43. [PMID: 19681054 DOI: 10.1002/jcp.21893] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
652 Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Suzuki T, Taguchi F, Tashiro M, Takemori T, Miyamura T, Tsunetsugu-Yokota Y. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. Virology 2006;351:368-80. [PMID: 16678878 DOI: 10.1016/j.virol.2006.03.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
653 Guan M, Chan KH, Peiris JS, Kwan SW, Lam SY, Pang CM, Chu KW, Chan KM, Chen HY, Phuah EB, Wong CJ. Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome. Clin Diagn Lab Immunol 2004;11:699-703. [PMID: 15242944 DOI: 10.1128/CDLI.11.4.699-703.2004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
654 Zhao J, Wang W, Wang GF, Li Y, Zhuang H, Xu X, Ren F, Zhao Z, Gao XM. Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus. J Clin Virol 2005;33:12-8. [PMID: 15797360 DOI: 10.1016/j.jcv.2004.09.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
655 Leung DT, Tam FC, Ma CH, Chan PK, Cheung JL, Niu H, Tam JS, Lim PL. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis 2004;190:379-86. [PMID: 15216476 DOI: 10.1086/422040] [Cited by in Crossref: 140] [Cited by in F6Publishing: 125] [Article Influence: 7.8] [Reference Citation Analysis]
656 Spurgers KB, Sharkey CM, Warfield KL, Bavari S. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses. Antiviral Res 2008;78:26-36. [PMID: 18258313 DOI: 10.1016/j.antiviral.2007.12.008] [Cited by in F6Publishing: 50] [Reference Citation Analysis]
657 Ren Y, He QY, Fan J, Jones B, Zhou Y, Xie Y, Cheung CY, Wu A, Chiu JF, Peiris JS, Tam PK. The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome. Proteomics 2004;4:3477-84. [PMID: 15378763 DOI: 10.1002/pmic.200400897] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
658 Tse TS, Tsui KL, Yam LY, So LK, Lau AC, Chan KK, Li SK. Occult pneumomediastinum in a SARS patient presenting as recurrent chest pain and acute ECG changes mimicking acute coronary syndrome. Respirology. 2004;9:271-273. [PMID: 15182281 DOI: 10.1111/j.1440-1843.2004.00569.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
659 Gretebeck LM, Subbarao K. Animal models for SARS and MERS coronaviruses. Curr Opin Virol. 2015;13:123-129. [PMID: 26184451 DOI: 10.1016/j.coviro.2015.06.009] [Cited by in Crossref: 108] [Cited by in F6Publishing: 97] [Article Influence: 15.4] [Reference Citation Analysis]
660 Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS. Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J Biol Chem 2006;281:15829-36. [PMID: 16597622 DOI: 10.1074/jbc.M600697200] [Cited by in Crossref: 191] [Cited by in F6Publishing: 137] [Article Influence: 11.9] [Reference Citation Analysis]
661 Liu J, Yu C, Yang Q, Yuan X, Yang F, Li P, Chen G, Liang W, Yang Y. The clinical implication of gamma-glutamyl transpeptidase in COVID-19. Liver Res 2021. [PMID: 34603826 DOI: 10.1016/j.livres.2021.09.001] [Reference Citation Analysis]
662 El-Manzalawy Y, Dobbs D, Honavar V. Predicting linear B-cell epitopes using string kernels. J Mol Recognit 2008;21:243-55. [PMID: 18496882 DOI: 10.1002/jmr.893] [Cited by in Crossref: 373] [Cited by in F6Publishing: 346] [Article Influence: 26.6] [Reference Citation Analysis]
663 Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
664 Lu B, Huang Y, Huang L, Li B, Zheng Z, Chen Z, Chen J, Hu Q, Wang H. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice. Immunology 2010;130:254-61. [PMID: 20406307 DOI: 10.1111/j.1365-2567.2010.03231.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
665 Yu YT, Chien SC, Chen IY, Lai CT, Tsay YG, Chang SC, Chang MF. Surface vimentin is critical for the cell entry of SARS-CoV. J Biomed Sci 2016;23:14. [PMID: 26801988 DOI: 10.1186/s12929-016-0234-7] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 11.8] [Reference Citation Analysis]
666 Xiao H, Xu LH, Yamada Y, Liu DX. Coronavirus spike protein inhibits host cell translation by interaction with eIF3f. PLoS One 2008;3:e1494. [PMID: 18231581 DOI: 10.1371/journal.pone.0001494] [Cited by in F6Publishing: 52] [Reference Citation Analysis]
667 Calleja DJ, Lessene G, Komander D. Inhibitors of SARS-CoV-2 PLpro. Front Chem 2022;10:876212. [DOI: 10.3389/fchem.2022.876212] [Reference Citation Analysis]
668 Zhou J, Li C, Zhao G, Chu H, Wang D, Yan HH, Poon VK, Wen L, Wong BH, Zhao X, Chiu MC, Yang D, Wang Y, Au-Yeung RKH, Chan IH, Sun S, Chan JF, To KK, Memish ZA, Corman VM, Drosten C, Hung IF, Zhou Y, Leung SY, Yuen KY. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv. 2017;3:eaao4966. [PMID: 29152574 DOI: 10.1126/sciadv.aao4966] [Cited by in Crossref: 205] [Cited by in F6Publishing: 191] [Article Influence: 41.0] [Reference Citation Analysis]
669 Zheng Y, Shang J, Yang Y, Liu C, Wan Y, Geng Q, Wang M, Baric R, Li F. Lysosomal Proteases Are a Determinant of Coronavirus Tropism. J Virol 2018;92:e01504-18. [PMID: 30258004 DOI: 10.1128/JVI.01504-18] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
670 Keng CT, Zhang A, Shen S, Lip KM, Fielding BC, Tan TH, Chou CF, Loh CB, Wang S, Fu J, Yang X, Lim SG, Hong W, Tan YJ. Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents. J Virol 2005;79:3289-96. [PMID: 15731223 DOI: 10.1128/JVI.79.6.3289-3296.2005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 4.0] [Reference Citation Analysis]
671 Liu TC, Chang WH, Jiang BC, Maa SH, Chien DK, Tang WR. Mortality Factor Survey of Severe Acute Respiratory Syndrome in Taiwan.